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1. Abstract
The Musashi RNA Binding Proteins Are Regulators of Alternative Splicing and Protein
Expression in Photoreceptor Cells.

Fatimah Kh Matalkah
The Musashi (Msi) family of RNA binding proteins consists of two paralogs, Msi1 and Msi2,
that are highly conserved across species. The two paralogs have emerged as factors that promote
stem cell proliferation by post-transcriptionally regulating translation. In addition to their
expression in stem cells, the Musashi proteins are also expressed in postmitotic neurons,
including the photoreceptor cells. The Musashi proteins have been observed to maintain high
expression levels in the postmitotic photoreceptors within the eye of both invertebrates and
vertebrates. These observations suggest an additional role in the maintenance of terminally
differentiated neurons.
Building upon these observations, we investigated the role of Musashi individually and in
combination in mature photoreceptors. Using a tamoxifen-inducible mouse model, I generated
single and combined deletion of Msi1 and Msi2 in mature photoreceptor cells. Our results show
that the Musashi proteins are required for the function and viability of mature photoreceptors.
Global analysis of the Msi1 targets in the retina showed binding to UAG motifs predominantly
located in introns and 3’-UTRs. Using RNA-sequencing and proteomics analysis, with the
incorporation of the publicly available single-cell RNA seq, we found that in mature
photoreceptors, the Musashi enhance the expression of proteins in high demand. Among these
targets are proteins needed for the daily regeneration of the light sensory organelle of the
photoreceptors. Collectively, the data provide new insights on the targets, possible molecular
mechanisms, and function of the Musashi in mature photoreceptors. The results support a model
of the Musashi proteins acting as a posttranscriptional activator for protein expression in mature
photoreceptors.

In the course of our work, an unusual behavior of the 13A4 antibody to prominin-1 (Prom1)
prompted us to analyze its epitope. Prom1 is a transmembrane protein with a role in the
morphogenesis of photoreceptor outer segment disk membranes. Mutations in the Prom1 gene
have resulted in various forms of retinal degeneration affecting rods and cones. Scanning deletion
mutagenesis and structural modeling demonstrated that mAB 13A4 recognizes a structural
epitope that is affected by the inclusion of the alternative exon 19 during photoreceptor
maturation. Consequently, the reactivity of mAB 13A4 towards the photoreceptor specific isoform
of PROM1 is significantly reduced on a Western blot leading to gross underestimation of PROM1
protein levels in the retina.
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1. Chapter 1
1.1 Diverse functions of RNA-binding proteins (RBPs)
RNA-binding proteins (RBPs) function in every step of the mRNA lifecycle. They associate
with mRNAs by binding to specific sequences or secondary structures to regulate processes that
include pre-mRNA splicing, polyadenylation, transport, translation, and stability (Figure 1) [1,2]. A
single RBP can regulate multiple mRNA targets, while one mRNA can be controlled by various
RBPs. Proper regulation of these processes is crucial for gene expression, and their perturbation
often leads to disease [3].

Figure 1-1 Posttranscriptional regulations mediated by the RNA binding proteins

Figure1: Posttranscriptional regulations mediated by the RNA binding proteins: Schematic
summarizing various functions for the RNA binding proteins in the mRNA lifecycle. Figure created
using Biorender.com.
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1.1.1 Pre-mRNA splicing
Pre-mRNA splicing is an essential step of the gene expression process in eukaryotes. The
process includes removing the introns from the pre-mRNA and joining the exons to produce
mature mRNAs [4,5]. Furthermore, since during splicing, each exon is recognized as an individual
module, the exon recognition process can be controlled so that individual genes produce multiple
transcript isoforms differing in their exon composition [6,7]. This process is called alternative
splicing and provides a major mechanism to expand the protein repertoire [7].
Splicing is carried out by a large RNA-protein complex known as the spliceosome [4]. Two
parallel spliceosomes exist in eukaryotes, a major spliceosome that is responsible for the excision
of most introns and a minor spliceosome that excises approximately 0.3% of introns [8]. The major
core spliceosome consists of five small nuclear ribonucleoprotein particles (snRNPs), U1, U2, U4,
U5, and U6 [9]. In the minor spliceosome U1 and U2 are replaced by the U11 and U12 snRNPs.
In addition to the five core snRNPs, a host of proteins is associated with the spliceosome and is
required to achieve efficient splicing [9]. The splicing reaction requires the spliceosome to
assemble in a stepwise manner onto each intron. The first step of this process is the recognition
of the sequence elements that define the intron/exon boundaries [10]. These sequence elements
include the 5' splice site (5'SS), the branch point, and the 3' splice site (3'SS) [7]. The differences
in the composition of the major and minor spliceosomes results in the two machineries
recognizing different splice site and branch point sequences [10]. Hence, the introns spliced by
the major spliceosome are called the U2-type, and the ones spliced by the minor spliceosome are
called the U12-type introns [10].
The initial assembly is undertaken by the recognition of the dinucleotide GU at the 5’ SS by
U1 snRNPs and the branch point (BP) by U2 snRNPs (major spliceosome), or the recognition of
AU at the 5’ SS and the BP by the U11/ U12 (minor spliceosome), respectively (Figure 2) [4,9].
Furthermore, the polypyrimidine tract (PPT) found in the U2-type introns is recognized by the
2

U2AF1/U2AF2 heterodimer (major spliceosome) (Figure 2) [11]. However, the AC dinucleotide
found at the 3’SS of U-12 type introns is recognized by a protein called ZRSR2 (minor
spliceosome) (Figure 2). The subsequent interaction between the U1/U2 snRNPs (major
spliceosome) or the U11/U12 (minor spliceosome) across the intron forms complex A, which
brings the 5' and 3' SS together by looping out the intron (Figure 2). The assembly of complex A
across the intron is known as the intron definition [10,12]. Once the A complex is formed the two
major and minor spliceosomes follow a similar assembly path. The next major assembly step is
binding the preassembled tri snRNPs U4/U6-U5 to complex A to form the precatalytic B complex
[8]. This is followed by the rearrangement of complex B resulting in the removal of U1/U11 and
U4 snRNPs and the formation of the active spliceosome (B*) [8]. Next, the active spliceosome
carries the splicing reaction that includes two transesterification reactions, the results of which
include the removal of the intron and the joining of the two adjacent exons [4,8].
The information contained in the consensus motifs of the 5' and 3' SS is typically insufficient
to identify the correct boundaries of most introns. This problem is further exacerbated by the large
size of metazoan introns that contain multiple sequences matching the splice site consensus.
Hence, additional sequence elements within the exons and their nearby intronic regions are
needed to correctly define the exon/intron boundaries. These additional cis-acting elements,
collectively known as the splicing regulatory elements (SREs), are recognized by various RBPs
[5]. The binding of the RBPs to SREs can either promote or block the assembly of the spliceosome
depending on the nature of the RBP and the position of its binding relative to the adjacent splice
site [13,14]. The SR family of RNA binding proteins are prototypical splicing activators that
facilitate exon recognition and recruit the spliceosome components to the correct splice sites [15].
These proteins consist of one or two RRM-type RNA binding domains and extensive
Serine/Arginine repeats from which the “SR”' name derives [16]. Another group of proteins, named
heterogeneous nuclear ribonucleoproteins (hnRNP) due to their association with various RNAs,
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was initially perceived as splicing inhibitors that block the use of cryptic splice sites [16]. It is
important to understand that RNA binding proteins can act as activators and repressors.
Recognizing the correct splice sites is a combinatorial process where RNA binding proteins
cooperate and compete to recruit the spliceosome to the correct splice sites and block the
recognition of cryptic splice sites. The balance of positive and negative regulators binding in the
vicinity of the splice sites determines the outcome of the exon recognition process and can be
controlled to cause the inclusion or skipping of exons depending on cell type or environmental
cues.
Interestingly, the binding positions of the RBPs relative to splice sites can either activate or
repress the splice site usage [17]. For example, the binding of Nova and Rbfox to the intronic
region downstream of the exon results in its inclusion. However, the binding to the upstream intron
results in exon skipping. The position-specific splicing regulation imposed by the RBPs on premRNA can be elegantly visualized by the integration of the in vivo binding sites identified by the
cross linking and immunoprecipitation (CLIP) and the events of alternative splicing identified by
the RNA-seq [17]. Integration of both tools coupled with bioinformatics analysis has enabled the
generation of "RNA splicing maps," a visualization tool that informs how the binding position
relative to the splice sites affects the direction in which each protein affects splicing [17].

4

Figure 1-2 Pre-mRNA splicing by the major and minor spliceosomes

Figure 2: Pre-mRNA splicing by the major and minor spliceosomes: 1) Splice site sequences
of major introns (U2-type) at the left side of the schematic and the minor introns (U12-type) at the
right side and the assembly of complex A across the introns. 2) The formation of complex B. 3)
The formation of complex B*/C. 4) The removal of intron and exon joining. Figure created using
Biorender.com.
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1.1.2 Pre-mRNA cleavage and polyadenylation
Polyadenylation of nascent transcript is another key step in the gene expression process
that, similar to splicing, is guided and regulated by RNA binding proteins. All mRNAs, except for
histone transcripts, are modified with a poly (A) tail at their 3' end in a process called
polyadenylation [18]. Adding the poly(A) tail facilitates the transport of the mRNA from the nucleus
to the cytoplasm and protects it from degradation. The length of the poly(A) tail affects the mRNA's
stability and rate of translation. While pre-mRNA polyadenylation is initiated in the nucleus, mRNA
polyadenylation can also occur in the cytoplasm. Nuclear polyadenylation is a two-step process
in which the nascent transcript is first cleaved, and a poly(A) tail is added by a specialized enzyme
[6]. The cleavage and polyadenylation reactions are carried out by a multiprotein complex that
binds to regulatory cis-elements found on the 3' UTR of the pre-mRNA [18]. The first regulatory
cis-element is the poly(A) signal (PAS) (AAUAAA) located 20-30 nucleotides from the cleavage
site [18]. The second regulatory sequence is a guanine and uracil G/U rich element located 30
nucleotides downstream of the cleavage site, thereby known as the downstream sequence
element (DSE) [18]. The third cis element is the dinucleotide of CA or UA at the cleavage site
located 20 to 30 nucleotides downstream of the PAS [18]. The first step of the polyadenylation
process is the cleavage of the primary transcript that is carried by the multiprotein complex
composed of more than 80 RNA-binding proteins [18]. These include the cleavage and
polyadenylation specificity factors (CPSFs), the cleavage stimulation factors (CstFs), and the
cleavage factor I and II (CFI, and CFII) [19]. The cleavage is initiated by the binding of the CPSFs
to the PAS and the CstFs to the DSE [18]. The interaction between the CPSF and CstF leads to
the recruitment of additional factors, including the CFI, CFII, and the Poly (A) polymerase, which
join around the cleavage site [18]. As the polyadenylation complex assembles, the pre-mRNA is
cleaved between the PAS and DSE elements. Then, the poly (A) polymerase is tethered to the
cleaved site of the pre-mRNA and starts adding the poly(A) tail to the 3' end [20]. Once in the
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cytoplasm, the poly (A) tail of the transcript is mostly coated with the cytoplasmic poly (A) binding
protein (PABP) [21]. The binding of the PABP either enhances or represses the transcript
translation by recruiting polyadenylating or deadenylating proteins, respectively [19].
Cytoplasmic polyadenylation is a mechanism the cell employs to activate the translation
of dormant mRNAs via the elongation of poly(A) tails in the cytoplasm [22].

This form of

translational control is utilized during multiple biological processes. For example, it is essential
during early development, oocyte maturation, and in the adult brain [23]. The common theme
among these processes is that transcription is either silenced or at a physiological distance from
the translation machinery [22].

Taking oocyte maturation as an example, generally, in the

immature oocyte, the dormant mRNAs would have a relatively short poly(A) tail consisting of
about 20 nucleotides or less [23]. However, during oocyte maturation, several mRNAs are
recruited to the polysome in a sequence-specific manner, and upon which the poly(A) tail on these
mRNAs grows to about 80 to 150 nucleotides. Increasing the length of the poly(A) tail promotes
the physical interaction between the 5’-end and 3’-end of the mRNA leading to its cyclization,
encouraging its association with multiple ribosomes, and enhancing its translation [24].
Cytoplasmic polyadenylation is mediated by the Germ-Line-Development-Defective-2 poly(A)
polymerase (GLD-2) and its orthologs. However, GLD-2 is a noncanonical cytoplasmic poly(A)
polymerase that lacks the RNA binding domain and is dependent on its protein partners to be
recruited to target mRNAs in a sequence-specific manner [25].
Not all mRNA are clients for cytoplasmic polyadenylation. As such, only RNA that
contains the cytoplasmic polyadenylation elements (CPEs) at their 3' end are targets for this
process. The CPE is a uracil-rich element with variable sequences; however, the most general
consensus sequence is the (UUUUUAU) [26]. In the cytoplasm, mRNA harboring the CPEs is
associated with several factors that control the poly (A) tail length. These include the CPE binding
protein (CPEB), the cytoplasmic form of the cleavage and polyadenylation specificity factor
7

(CPSF), the scaffolding protein Symplekin, and the cytoplasmic poly(A) polymerase Gld-2 [24]. In
addition to CPEB, several other proteins, including GLD-3, RNP-8, Musashi, Pumilio, and Nanos,
have been shown to recruit GLD-2 and control cytoplasmic polyadenylation [27].
1.1.3 RNA turnover
The mRNA turnover is another process that the RBPs mediate. It is a highly regulated
process in the cytoplasm and plays a crucial role in regulating the transcript level [28]. The RBPs
regulate mRNA turnover by binding to cis-elements found in the 3' UTR of the transcript; the beststudied one is the adenylate and uridylate-rich element (AU-rich elements (AREs)). Interestingly,
the binding of different RBPs to the same cis element has been shown to either stimulate or
prevent mRNA decay. For example, Human antigen R (HuR) and tristetraprolin (TTP) are among
the proteins that play a role in regulating the mRNA turnover [29]. These two proteins compete
for the same AREs on the 3’UTR of a transcript. For example, it has been shown that the binding
of HuR, a member of the ELAV family of RBPs, to the ARE inhibits the rapid mRNA turnover. The
stabilizing effects of HuR are due to the competition with destabilizing proteins for the binding
ARE on the mRNA. However, the binding of the TTP, a zinc finger protein, to the ARE promotes
mRNA decay by stimulating the deadenylation of the transcript [29].
In eukaryotes, there are two pathways of mRNA decay, both of which are initiated by the
removal of the poly (A) tail (deadenylation) [28]. In the first pathway, removing the poly (A) tail
stimulates the hydrolysis of the mRNA cap structure and the subsequent degradation of the
mRNA by the 5' exonucleases [28,30]. In the second pathway, the mRNA is degraded by a
complex of 3′ exonucleases with no need for the hydrolyzation of the cap structure [28,30].
Degradation of mRNA occurs at specific loci within the cytoplasm known as the processing bodies
(P-bodies). The P-body is where the mRNA decay factors are localized [28]. These include the
deadenylase, decapping enzymes, and exonucleases that drive the mRNA degradation.

8

Similarly, multiple microRNAs (miRNA) can also regulate mRNA turnover. These small
RNAs bind to regulatory elements in the 3’ UTR of their target RNA with an imperfect match [31].
More than 60% of the mammalian genes are estimated to have at least one miRNA-binding site
[32]. The binding of the miRNA to the target mRNA recruits Argonaute (Ago) proteins and
GW182/TNRC6 to form the RNA-induced silencing complex (RISC). This is followed by the
recruitment of several factors and enzymes that stimulate mRNA cleavage and degradation,
including major deadenylase, decapping enzymes, 3′ and 5′ exonucleases, and endonucleases
[33]. The consequence of this is either an increased rate of mRNA decay or translational
repression.
1.1.4 Regulation of translation
The translation process is divided into three phases: initiation, elongation, and termination.
The initiation phase consists of multiple steps that include the association of the eukaryotic
initiation factors (eIFs) with the 5'cap and the subsequent recruitment of the 40S ribosomal subunit
to form the scanning complex (Figure 3) [34]. The first step of initiation includes binding the eIF1, eIF-1A, and eIF-3 to the 40s ribosomal subunit (Figure 3) [35]. Then the initiator methionyl
tRNA is brought to the ribosome by eIF-2 (in complex with GTP) [35]. The recruitment of the
mRNA to the 40s ribosome then follows, mediated via the cap binding complex eIF-4E (Figure 3).
Another factor, the eIF-4G, is then recruited. The eIF-4G can bind both the eIF-4E at the 5’ end
and the PABP located at the 3’ end, a step that promotes mRNA circulation and ribosomal
recycling, promoting efficient translation [35]. The complex then starts scanning the 5' end of the
transcript for the first AUG codon in the correct context (Figure 3). Once the start codon is
recognized, this is followed by recruitment of the 60s subunit and the subsequent assembly of the
80s ribosome [35]. Then, the elongation factors are recruited, and translation is initiated [35]. The
translation proceeds until a stop codon is reached and recognized by the termination factors [34].
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The RNA-binding proteins can modulate the translation level at any of the three steps [35].
One of these mechanisms includes binding the RBPs to the preinitiation complex and
subsequently blocking the circularization step of the mRNA to repress translation [35]. The
Musashi proteins are among the RBPs that have been reported to regulate the translation of its
target transcripts by interfering with the preinitiation complex assembly. For example, Msi1
competes with eIF-4G for the PABP, blocking the circularization step of the mRNA [36]. Another
mode of regulation is to prevent the binding of the 60s ribosomal subunit to the 40s ribosomal
subunit [37]. The heterogenous nucleoproteins K and E (hnRNPK and hnRNPE1) are among the
RNA-binding proteins that have been shown to intervene with the translation by blocking the
assembly of the two subunits [37]. By binding to a CU-rich element found in the 3’UTR of their
target transcript, hnRNPK and hnRNPE1 target the transcript to ribonucleoproteins (RNPs) from
which the 60s is excluded [35]. RBPs can also interfere with the elongation step. In this case, the
binding of the RBPs to the coding sequence will stall the 80s ribosome on the target mRNA [35].
An example of this mechanism is the fragile X mental retardation protein (FMRP), a neuronal RNA
binding protein known to negatively regulate translation by binding to the coding sequence stalling
the ribosomal translocation [35]. Collectively, by binding to cis elements found at the 5’ and 3’
UTRs or the coding sequence of the mRNA, the RBPs can control the rate of translation and
subsequently direct protein expression required in response to the cellular demand.
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Figure 1-3 The translation initiation phase in eukaryotes

Figure 3: The translation initiation phase in eukaryotes: The schematic outlines the initiation,
which starts by binding eIF-3, -1, and -1A to the 40s ribosome. The eIF-2 brings the initiator
methionyl tRNA to the ribosome, and the mRNA is brought by eIF-4E (which binds to the 5´ cap).
The eIF-4G then binds both the eIF-4E complex and the PABP. The ribosome then starts
scanning the mRNA for the AUG initiation codon. Figure created using Biorender.com
11

1.2 Photoreceptor cells
1.2.1 Structure and function
Vertebrates rely on the photoreceptor cells, the light-capturing cells within the retina, for
image-forming vision [38]. There are two types of photoreceptor cells: rods and cones. The rods
specialize in night vision as they are extremely sensitive to light and can detect a single photon,
while cones mediate daylight and color vision, respectively [38]. Cones can be further classified
into different subtypes depending on the absorption maxima of the visual pigment they contain.
These include the S-type, the M-type, and the L-type, which are highly sensitive to the blue, green,
and red colors [38]. Both cones and rods are compartmentalized cells consisting of four structural
regions: The outer segment (OS), the inner segment (IS), the cell body, and the synapse terminal.
The OS function is to capture light and, in response, trigger electrochemical signals in a process
known as phototransduction. Structurally, the OS is a primary cilium with an elaborate stack of
membrane disks [39]. The disks are densely packed with the visual pigment, rhodopsin or cone
opsin, and other proteins that are necessary for the phototransduction cascade (Figure. 4-section
1.2.2) [38]. The dense stacking of the disks increases the efficiency of photon capture [5]. The
OS is constantly regenerated throughout the lifetime of photoreceptor cells to ensure maximum
photosensitivity [39,40]. The process of regeneration occurs daily, with 10-15% of the OS at the
distal end being removed by phagocytosis by the retinal pigmented epithelial cells (RPE), and
new membrane stacks filled with proteins are continuously added to the base of the OS to
compensate for the loss at the tip [39,40].
The OS is connected to the inner segment via a narrow bridge-like structure called the
connecting cilia [40]. The inner segment is the place where protein and lipid synthesis take place.
All the proteins that are residents of the OS are synthesized in the IS and then transported via the
connecting cilia to reach their final destination in the OS [40]. In the mammalian retina, the nuclei
of photoreceptor cells are stacked on top of each other, forming the outer nuclear layer (ONL)
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[40]. The photoreceptors connect to the downstream bipolar and horizontal neurons via ribbontype synapse that is densely packed with synaptic vesicles containing the neurotransmitter
glutamate. The synaptic ribbon is a proteinaceous structure anchored to the plasma membrane
at the active zone and extends to the cytoplasm [41]. The main function of the synaptic ribbon is
to anchor a large number of the readily releasable vesicles at the presynaptic zone to increase
the release rate upon the signal arrival [41]. The signal is then passed to the inner neurons within
the retina for further processing and subsequently into the midbrain for visual reflexes, and to the
thalamus and visual cortex within the central nervous system for additional processing and for
conscious vision.
1.2.2 Phototransduction in rod photoreceptor cells
In the vertebrate rod photoreceptor neurons, image-forming vision starts with the
absorption of the light photons by the retinal chromophore covalently attached to the rhodopsin
molecule [38]. This results in the isomerization of the chromophore from 11-cis to all-trans isomer,
causing a conformational change in the C-terminal domain of the rhodopsin molecule allowing it
to interact and activate transducin, a heterotrimeric G protein composed of 3 subunits G𝞪, Gβ
and Gγ(Figure 4) [38,39]. Upon the binding of rhodopsin to transducin, it catalyzes the exchange
of GDP to GTP on the G𝞪 subunit and subsequently activates it [38,39]. Once activated, the G𝞪
dissociates from its native partner Gβγ and diffuses in the disc membrane until it encounters the
phosphodiesterase enzyme (PDE) (Figure 4). PDE is a tetrameric protein consisting of two
catalytic subunits 𝞪 and β, and two identical inhibitory γ subunits. In the dark the two γ subunits
bind to the catalytic domain of 𝞪 and β subunits inhibiting the hydrolysis of cGMP (Figure 4). In
the light, once G𝞪-GTP encounters PDEγ subunits it sterically displaces it from the catalytic site
relieving the inhibition and permitting the hydrolysis of cGMP to GMP by the PDE𝞪 and PDEβ
subunits [38]. The decline in cGMP level upon hydrolysis leads to the rapid closure of the cGMPgated channel (CNG), a nonselective cation channel found in the plasma membrane of the
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photoreceptor cell [37,38]. The closure of the channel upon illumination ceases the Na+ and Ca2+
influx resulting in the hyperpolarization of the rod photoreceptor cell and subsequently inhibits the
release of glutamate at the synaptic terminal [38]. The channel closure is the final step in the
phototransduction cascade, after which the photoreceptor cell must reset and return to the dark
state. The recovery step starts with the phosphorylation of rhodopsin at multiple serine/threonine
residues found at the C-terminal by the G-protein coupled receptor kinase (GRK1) [38]. The
phosphorylation of rhodopsin decreases its activity, creating binding sites for a protein known as
arrestin [38,39]. The binding of arrestin further reduces rhodopsin activity and subsequently
abolishes its ability to activate transducin (Figure 4). Then PDE is returned to its dark state when
the PDE© subunits bind to the catalytic domain blocking the entry to the active site on the PDE𝞪
and PDEβ [38]. In addition, the cGMP level rises again following the activation of the
transmembrane protein guanylate cyclase (GC) through the Ca+2 sensor guanylate-cyclaseactivating proteins (GCAPs) (Figure 4). This occurs upon illumination when the GCAPs sense the
decline in Ca+2 concentration and subsequently activate GC to mediate the synthesis of cGMP
[39]. The rise in the level of cGMP leads to the opening of the CNG channel and the subsequent
depolarization of the photoreceptor cells (Figure 4). Finally, to regenerate rhodopsin, the all-trans
retinal must be converted back to all-cis [38,39]. The regeneration process is initiated in the
photoreceptor cells and then completed in the RPE via a biochemical pathway called the visual
cycle [42]. The initial reaction occurs in the photoreceptor cell, where all- trans-retinal is converted
to all-trans-retinol before being transferred into the adjacent RPE [43]. In the RPE, after an
esterification step, the all-trans-retinol is converted to all-cis-retinol by the isomerhydrolase
RPE65 [42]. Then it is oxidized back to 11-cis-retinal before being sent back to the photoreceptor
neurons to be combined with opsin [42].
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Figure 1-4 Phototransduction cascade in rod photoreceptor cells

Figure 4: Phototransduction cascade in rod photoreceptor cells: Schematic outlines the
phototransduction cascade in the vertebrate’s rod photoreceptor cells. The cascade is initiated by
the absorption of light photons by the chromophore within the rhodopsin molecule leading to its
isomerization and the activation of the phototransduction cascade resulting in the closure of the
cGMP-gated channel and the subsequent hyperpolarization of the photoreceptor cells. Figure
created using Biorender.com
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1.3 The Musashi RNA binding proteins
The Musashi (MSI) family is an evolutionary conserved group of RNA-binding proteins in
metazoans. Two Musashi paralogs, MSI1 and MSI2, exist in vertebrates originating from gene
duplication events [44]. Thus, the invertebrates contain only the gene of the first member (MSI1).
Prokaryotes, plants, and single-cell organisms lack the Musashi gene, suggesting that the
Musashi are required in metazoans [45]. The characterization of the first member of the Musashi
family (MSI1) was in Drosophila in 1994. The Drosophila Musashi (d-MSI) is highly expressed in
various precursor cells of the embryonic CNS and was found to be essential for the asymmetric
cell division of the ectodermal sensory hair-like structure known as the sensory organ precursors
(SOPs) [46]. The sensory organ precursor cell normally goes through two successive asymmetric
cell divisions giving rise to a bristle, a hair-like structure composed of a shaft, a socket, a glia, and
a neuronal cell. However, a mutation affecting the d-MSI leads to a double shaft and double socket
phenotype at the expense of the glia and neuronal cells [46]. This results from the loss of the
asymmetric division of the SOPs, causing both secondary precursor cells to assume the same
fate [46]. The resemblance of the double shaft phenotype to the great samurai Miyamoto
Musashi’s two swords leads to the gene's name after the samurai [46].
The Musashi protein was implicated in the function of the stem cells of a more primitive
invertebrate such as the ascidians [47]. Similarly, in vertebrates, the Musashi are highly enriched
in the developing central nervous system (CNS) and an essential element in controlling the stem
and progenitor cell function. Notably, the expression of MSI1 and MSI2 was mainly detected in
the proliferating precursor cells localized within the ventricular zone (VZ) of the neural tube in the
embryos and the neurogenic sites within the postnatal brain, including the subventricular zone
(SVZ), olfactory bulb, and the ependyma [48–51]. The Musashi proteins were also identified in
other embryonic and adult stem cells such as the eye, intestine, skin, breast, and hematopoietic
cells [52–57]. With their preferential expression in neuronal stem cells, the Musashi proteins have
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emerged as developmental regulators maintaining the self-renewal capacity of stem cells.
AlthoughF Musashi was first described in stem cells and in proliferative neural progenitor cells, it
is also expressed in postmitotic neurons [51]. For example, the Musashi proteins have been
observed to maintain high expression levels in the postmitotic photoreceptors within the eye of
both invertebrates and vertebrates [52–54,58].
1.3.1 Musashi structure
The Musashi proteins share high sequence similarity at the primary and tertiary structures,
with a 68% amino acid identity on the overall structure (Figure 5). The Musashi family belongs to
the heterogeneous nuclear ribonuclear class of proteins (hnRNPA/B) characterized by having two
copies of RNA recognition motifs that mediate the binding to mRNA. Both MSI1 and MSI2 contain
two RNA recognition motifs (RRM1 and RRM2) tandemly positioned at the N-terminus. The RRM
is one of the highly conserved folds that has been shown to interact with nucleotide sequences
ranging from two to eight nucleotides in length [59]. Like other RRMs, each of the Musashi RRMs
consists of four antiparallel β-sheets wrapped by two 𝞪-helices and contain the highly conserved
ribonucleoprotein type-1 (RNP1) and ribonucleoprotein type-1 (RNP2) consensus sequences
(Figure 5).The consensus sequences of the RNP1/2 are characterized by the presence of
aliphatic and aromatic amino acids (Figure 5, yellow highlight) which provides the surface for the
interaction and play an important role in substrate recognition [60]. The MSI1 binding motif was
determined to include a consensus sequence of (G/A) UnAGU by in vitro selection tool using a
pool of degenerate 50-mer sequences [61]. Further structural and biochemical studies
demonstrated the preference of Musashi binding to a core motif of r(GUAG) and r(UAG) to be
mediated by RRM1 and RRM2, respectively [59,60]. Mutation analysis has shown that
nucleotides outside the UAG core motif have little impact on the binding energy [59].
Aromatic base stacking and intermolecular hydrogen bonding between the core
nucleotides r(UAG) and the conserved aromatic amino acids within the RNP1/2 region are the
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two types of interactions that initiate substrate recognition [60,62]. Notably, the important residues
for RNA-binding are highly conserved in MSI1 and MSI2 proteins (Figure 5-highlighted in yellow).
This raises the possibility that both MSI1 and MSI2 may recognize the same targets and explains
the frequently reported functional redundancy between the two paralogs, a possibility that is
supported by the observation that the knockdown of Msi2 in the Msi1-/- neuronal stem cells
significantly decreases neurosphere formation [51]. The C-terminals of MSI1 and MSI2 are
different in length, and the amino acid sequence share only 56% identity. Three protein-interacting
domains were identified in the C-terminal of the MSI1, including the PolyA- binding protein domain
(PABPD), the LIN-28 binding domain (LIN28-D), and the GLD2 binding domain [25,36,63]. The
PABP and GLD2 bind directly to amino acids 190-240 and 190-220 located at the C-terminal
region of MSI1, respectively (Figure 5). However, a search for the binding region for LIN-28
identified 13 amino acids 246-265 as a putative binding site for LIN-28 in MSI1 [63]. Interestingly,
the primary sequence of MSI2 lacks the LIN-28 domain (Figure 5), suggesting that the regulation
of miRNA biogenesis is probably a unique function of MSI1 [63]. Similarly, only MSI1 and not
MSI2 can interact with GLD2 [25]. As per their subcellular localization, the Musashi proteins are
present in the cytoplasm and the nuclear compartment. Two putative nuclear localization signal
(NLS) sequences are present in the RRMs of the two paralogues (Figure 5). A classical NLS and
a peptide-like NLS (Figure 5, red color). Nevertheless, it was postulated that when the Musashi
proteins bind their target in the cytoplasm, the NLS is blocked due to their location within the
RRMs and subsequently trapping it in the cytoplasm.
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Figure 1-5 Sequence alignment of the mouse MSI1 and MSI2 and the 3D structural prediction by Robetta

Figure 5: Sequence alignment of the mouse MSI1 and MSI2 and the 3D structural prediction
by Robetta. Identical residues within the RNP1 and RNP2 of Msi1 and MSI2 are highlighted in
yellow. In the 3D structure, the MSI1/2 RRM1 and RRM2 domains are indicated in the pink and
blue colors, respectively. Although NMR has resolved the RRMs structure, the full-length 3D
structure is still to be elucidated. Here Robetta was used to predict the overall 3D structure of the
mouse MSI1 and MSI2.
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1.3.2 Mechanisms of posttranscriptional regulation by Musashi proteins
The Musashi proteins are localized to the cytoplasm and nucleus, supporting the notion
that they regulate various processes in mRNA metabolism. Consistent with their expression in the
cytoplasm, the Musashi proteins have emerged as master regulators of translation. It has been
shown that the Musashi can positively or negatively regulate the translation of their target
transcripts without affecting their mRNA level. For example, while MSI1 acts as a translational
repressor in the mammalian cells, it switches to an activator of translation in the context of the
Xenopus oocytes [36,64]. This was shown elegantly when the Xenopus and mouse MSI1 was
expressed in mammalian cells; they repress translation. However, they act as an activator of
translation when expressed in Xenopus oocytes, suggesting that the switch is not due to speciesspecific differences in the protein but instead is context-dependent [64]. The proposed mechanism
of translational repression in mammalian cells involves the direct binding of MSI1 via a region
within its C-terminal half to the poly-A binding protein (PABP) [36]. Previous work by Kawahara
et al. showed that the binding of MSI1 to the 3’ end of m-Numb mRNA, which encodes Notch
antagonist, inhibits its translation at the initiation step. The proposed model includes the
simultaneous binding of MSI1 via its RRM to the 3’ end of its target transcript and to the Poly (A)
binding protein (PABP) via its C-terminal domain, competing with the eIF4G for the PABP and the
subsequent inhibition of 80S ribosome complex formation [36].
In contrast, Cragle and MacNicol reported in the context of the Xenopus oocytes that MSI1
interacting with the Poly (A) binding protein (PABP) stimulates translation of its target transcript,
acting as an activator rather than an inhibitor of translation [65]. However, the mechanism of
activation proposed by Cragle and McNicol is not fully understood. One of the proposed
mechanisms for the bifunctional behavior of Musashi is either through posttranslational
modification of the Musashi protein and/or the association with different protein co-factors [64,65].
The Musashi has also been linked to the cytoplasmic adenylation apparatus. Previous work by
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Cragle et al. showed that MSI1 could interact with the cytoplasmic poly(A) polymerase GLD-2
[25]. The researchers mapped the interacting domain to 31-amino acids within the C-terminal
region of MSI1 (amino acids 190–220), which lies directly outside the two N-terminal RNA
recognition motifs of MSI1 (Figure 5). Therefore, the authors proposed that MSI1, through its
interaction with GLD-2, serves as the guide to selectively recruit GLD-2 to specific mRNA
transcripts, promoting their cytoplasmic adenylation and translation, and subsequently linking the
MSI1 protein to the polyadenylation apparatus via its interaction with GLD-2.
In the nucleus, the Musashi proteins have been shown to regulate alternative splicing and
to be involved in the miRNA biogenesis. The binding of MSI1 to the LIN-28 blocks neuronal
differentiation by inhibiting the maturation of the let-7 family of miRNA miR98 at the cropping step
[63]. Alternatively, our lab, among others, demonstrated a role for the Musashi proteins in
regulating alternative splicing in photoreceptor cells [52,66–68]. We show that the Musashi
regulate the splicing of a set of pre-mRNA, many of which belong to cilia-related genes, to produce
photoreceptor-specific isoforms [52,68].
1.3.3 Musashi in photoreceptor cells
In addition to their predominant expression in neuronal stem and progenitor cells, the
Musashi proteins have been shown to be expressed in a small population of postmitotic neurons,
including the photoreceptor cells [51]. The expression of the Musashi proteins in mature
photoreceptors has been validated in animal models, including Xenopus Leavis, mouse retina,
and newt retina [53,69–71]. In the developing mouse retina, the subcellular localization of MSI1
changes from being exclusively cytoplasmic in retinal progenitor cells to transiently become
nuclear in differentiating cells and then shifting predominately perinuclear and cytoplasmic in the
mature retina [69]. A critical role for MSI1 in retinal development and survival has been established
in both Drosophila and mammals [52,54,58]. In Drosophila, loss of function in d-MSI resulted in
weak abnormalities in the photoreceptor differentiation. However, the phenotype significantly
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increased in the background of seven absentia (Sina) knockouts [58]. It has been shown that in
the developing Drosophila eye, both the d-MSI and Sina function redundantly by controlling the
expression level of Tramtrack (Ttk), a transcriptional regulator of neuronal cell fate [58]. As such,
loss of function in d-MSI and Sina resulted in ectopic expression of Ttk that was accompanied by
a failure in photoreceptor specification [58]. In mammals, the functional role of Musashi proteins
in photoreceptors has been investigated following constitutive and conditional germline deletions.
For example, Susaki et al. [9] show that global embryonic deletion of the Msi1 gene results in the
eventual death of photoreceptors. They attributed the photoreceptor cell death to a non-cell
autonomous effect caused by a malfunction in the retinal pigmented epithelium (RPE). They
proposed that the failure of RPE65, a visual cycle protein, to localize to the microvilli of RPE has
influenced photoreceptor survival. Building upon this work, our previous work showed the
combined deletion of Msi1 and Msi2 in photoreceptor progenitor cells caused severe
morphological defects in the outer segment (OS) that was accompanied by progressive
degeneration, which ultimately led to the loss of vision [52]. In addition to its cytoplasmic
expression, our published work shows the Musashi proteins are also localized in the
photoreceptor nuclei [66]. We show that besides being a translational regulator, the Musashi
proteins function as splicing regulators promoting the inclusion of a set of alternatively splice
exons to generate a photoreceptor-specific isoforms [52,66]. The localization of the Musashi
proteins to the nuclei and cytoplasm of photoreceptor cells suggests that the Musashi proteins
might have a compound role where they regulate mRNA splicing in the nucleus and its translation
in the cytoplasm.
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1.4 Summary and aims of the thesis
The Musashi proteins are widely known to support stem cell maintenance and selfrenewal. By being highly expressed in stem cells, most of the previous work had focused on
characterizing the Musashi protein's mechanistic role in stem cells of various cellular systems.
Few, if any, had investigated their role in postmitotic tissues. Germline and targeted embryonic
deletion of Msi1/2 established a role for Musashi proteins in photoreceptor function and survival
and supported functional redundancy between the two paralogs [52,54,58].
Interestingly, our recently published results showed that the Musashi proteins maintain an
exceptionally high protein level in the mature retina [52]. We observed the expression of the two
paralogs to be developmentally regulated, with MSI1 predominating early around postnatal day 4
(PN4) and MSI2 prevailing after PN13 [52]. Single deletion of Msi1 or Msi2 in committed rod
progenitor cells showed that the two paralogs are partially redundant and appear to act differently
at different time points of retinal development [52]. As such, the single deletion of Msi1 resulted
in an early visual defect that was observed at the time point of eye-opening in mice (PN16), while
the removal of Msi2 resulted in a visual defect that was detected at a later time point when
photoreceptors were fully developed [52]. Building upon these findings, we hypothesize that MSI2
may have a unique role in maintaining mature photoreceptor cells, with MSI1 unable to
compensate for MSI2 Loss. To test our hypothesis, we sought to investigate the functional role of
the Musashi individually and in combination in mature photoreceptors.
To understand the role of the Musashi proteins in mature photoreceptor cells, we utilized
an inducible mouse model that allows for deleting Musashi proteins from mature photoreceptors.
We generated single and combined deletion of Msi1 and Msi2. Additionally, how the Musashi
regulate their targets, what processes they regulate, or what targets they bind in photoreceptor
cells is not fully understood. To answer these questions, I used the genome-wide sequencing
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approach eCLIP, RNA sequencing, and proteomics analysis to define the mechanistic role of the
Musashi in the retina. This is the first study that combines all three global wide analyses to
delineate the mechanistic role of the Musashi proteins in the mouse retina.
Chapter 2 describes the functional role of MSI1 and MSI2 in mature photoreceptor cells
and illustrates the binding interactions and potential targets of Musashi proteins in the retina as
determined through eCLIP-seq, RNA sequencing, and proteomics analysis [72]. The results
provide insights into the molecular mechanisms mediating the functional role of Musashi in
photoreceptors [72]. Chapter 3 illustrates the efforts to map the epitope of the widely used rat
monoclonal antibody mAB 13A4 to the mouse Prominin-1 protein [73]. We show that the mAB
13A4 recognizes a structural epitope that gets disrupted by the inclusion of the photoreceptorspecific exon (exon 19), interfering with Prominin-1 detection on a Western blot analysis [73]. In
chapter 4, I discuss the results and conclude by suggesting experimentation that builds upon and
extends this study's framework.
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2.2 Abstract
The Musashi proteins, MSI1 and MSI2, are conserved RNA binding proteins with a role in
the maintenance and renewal of stem cells. Contrasting with this role, terminally differentiated
photoreceptor cells express high levels of MSI1 and MSI2, pointing to a new role for the two
proteins in vision. Combined knockout of Msi1 and Msi2 in mature photoreceptor cells abrogated
the retinal response to light and caused photoreceptor cell death. In photoreceptor cells, the
Musashi proteins perform distinct nuclear and cytoplasmic functions. In the nucleus, the Musashi
proteins promote the splicing of photoreceptor-specific alternative exons. Surprisingly, conserved
photoreceptor-specific alternative exons in genes critical for vision proved to be dispensable,
raising questions about the selective pressures that lead to their conservation. In the cytoplasm,
MSI1 and MSI2 activate protein expression. Loss of Msi1 and Msi2 leads to a reduction in the
levels of multiple proteins including proteins required for vision and photoreceptor survival.
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2.3 Introduction
Mammals express approximately 500 RNA binding proteins that associate with
Polymerase II transcripts to regulate pre-mRNA processing, mRNA localization, mRNA stability,
and translation 1. Networks of RNA binding proteins specific to, or highly expressed in neurons
perform roles that range from diversifying the transcriptome through alternative splicing and polyadenylation to directing transport of specific mRNA to cellular compartments for localized
translation 1–4. RNA binding proteins are essential for the development and function of the nervous
system where processes such as axon guidance, synaptic plasticity, cell survival and cell
excitation are tuned by their activity 4. Many RNA binding proteins belong to families of orthologs
with varying degrees of sequence homology and functional redundancy. Interestingly, even
orthologs with highly similar sequences and biochemical properties are not fully redundant and
can have distinct roles in the nervous system. This divergence in function can be derived from
differences in expression levels across different cell types, subcellular localization, or their
interactomes 5–8.
Neurons stand out among other cell types by the pervasive use of alternative exons

9,10

.

The large number of alternatively spliced exons used in neurons is due to the absence of a major
splicing repressor, PTBP1, and the expression of neuron specific splicing factors 4. While the
importance of neuronal splicing programs is well established through knockouts of splicing
regulators, the functions of the many alternative exons are less clear. Functional significance of
individual exons is commonly assigned based on sequence conservation and the nature of the
protein hosting the exon. More recently, an empirical picture of the functional impact of individual
exons has started to emerge. Functions of individual exons range from fine-tuning protein
interactions to regulatory switches that shut down protein expression 11–13. Interestingly, in several
cases, deletion of conserved alternative exons has failed to produce an obvious phenotype in
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14–17

mouse models in vivo

.

Among the RNA binding proteins expressed in neurons are the Musashi family of proteins
18–20

. The founding member of the family, the Drosophila Msi protein was first described as a factor

that maintains the undifferentiated state of stem cells by repressing the translation of the Notch
regulator Numb

21

. This function of Musashi is preserved in vertebrates where its homologues,

MSI1 and MSI2, are required for stem cell maintenance and are investigated for their role in
cancer progression

22–25

. Subsequent studies showed that the effect of the Musashi proteins on

translation is context dependent, and they can positively or negatively regulate protein translation
by binding to the 3’-UTR of their target mRNAs 26–29.
We showed that in photoreceptor cells the Musashi proteins regulate alternative splicing
to produce highly photoreceptor-specific isoforms of ubiquitously expressed proteins

30,31

. The

Musashi proteins maintain exceptionally high protein levels in the mature retina and their
expression is developmentally regulated

31

. MSI1 levels rise sharply after birth, peak between

postnatal days 2 and 4, and decline afterwards. Concomitant with the decline of MSI1 protein
levels, the levels of MSI2 increase and remain constant in adulthood

31

. Single deletion of Msi1

or Msi2 in committed rod photoreceptor progenitor cells showed that the two paralogs are partially
redundant and appear to act at time-points of retinal development that correlate with the pattern
of their expression

31

. The single deletion of Msi1 results in an early visual defect that was

observed at the time of eye-opening in mice (postnatal day 16). In contrast, the removal of Msi2
resulted in normal vision at postnatal day 16 that progressively declined with age

31

. Based on

these findings, we proposed that MSI2 is involved in the maintenance of mature photoreceptor
cells, while MSI1 functions in photoreceptor precursors and immature photoreceptor cells.
Using an inducible mouse model that deletes the Musashi genes in mature photoreceptors
we show the Musashi proteins to be essentials for the function and viability of the photoreceptors.
To our surprise, despite their reciprocal regulation during development, MSI1 and MSI2 are fully
redundant in mature photoreceptors. We identified the transcripts recognized by MSI1 and MSI2
34

in vivo and investigated how loss of the Msi1 and Msi2 genes affected pre-mRNA splicing,
transcript levels, and protein expression. We demonstrate that the Musashi proteins bind
downstream of photoreceptor-specific exons to activate their splicing. In addition, we show that in
photoreceptors the Musashi proteins act almost exclusively as post-transcriptional activators of
protein expression.

2.4 Results
Depletion of Msi1 and Msi2 in mature photoreceptor cells
We recently showed that in the retina the MSI1 and MSI2 proteins are differentially
regulated and proposed that they have separate roles in development and maintenance of
photoreceptor cells

31

. We tested the roles of the Musashi protein in mature photoreceptors by

using tamoxifen-inducible CreERT2 under the control of rod-specific Pde6g promoter to remove
Msi1 and Msi2 in mature rod-photoreceptor cells

. Floxed (Msi1flox/flox/Msi2flox/flox) mice
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hemizygous for Pde6g-CreERT2 were injected with tamoxifen for three consecutive days starting
at postnatal day 30 to create combined Msi1/Msi2 knockout mice. Littermates carrying the floxed
alleles for Msi1 and Msi2 (Msi1flox/flox/Msi2flox/flox) and treated with tamoxifen were used as controls.
We will refer to the Msi1flox/flox/Msi2flox/flox treated with tamoxifen as Msi1+/+/Msi2+/+ and the mice
with

Msi1flox/flox/Msi2flox/flox-Pde6gCreERT2

treated

with

tamoxifen

as

Msi1-/-/Msi2-/-.

Immunocytochemistry (ICC) demonstrated that, 14 days after the first tamoxifen injection, the
MSI1 and MSI2 proteins were depleted specifically from the photoreceptors (Figure 1A). The
immunofluorescence signal is lost from both the cytoplasm (inner segment, IS) and the nuclei
(outer nuclear layer, ONL) of the photoreceptor cells. Consistent with the ICC data, western blot
analysis showed two-fold decrease in the MSI1 and MSI2 protein levels in retinal lysates from the
Msi1-/-/Msi2-/- mice (Figure 1B and Supplement Figure 9).
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MSI1 and MSI2 are required for the function and survival of mature photoreceptors
To evaluate the functional significance of Musashi proteins in mature photoreceptors, we
used electroretinograms (ERG) to measure the retinal response to light. We measured the darkadapted (scotopic) and the light-adapted (photopic) responses that reflect rod and cone
photoreceptor function, respectively

33

. We used repeated measures two-way ANOVA to

determine the effect of the genotype and time post injection on the ERG A-Wave amplitude. We
found a significant interaction of the genotype and the time after injection (Scotopic response:
F(12,1)= 19.47, p-value<0.0001; Photopic response: F(12,1)=10.37, p-value<0.0001). The
response to light of the Msi1-/-/Msi2-/- animals and the age-matched Msi1+/+/Msi2+/+ controls
became significantly different 35 days after tamoxifen injection (Figure 2A, B). The response to
light continued to decrease rapidly thereafter and was nearly undetectable by day 105 postinjection (Figure 2A, B).
To assess the retinal morphology following Msi1/Msi2 deletion, we performed hematoxylin
and eosin (H&E) staining on retinal cross-sections collected from Msi1-/-/Msi2-/- and control mice
between days 0 and 113 post-injection (Figure 2C, D, and Supplement Figure 2). A significant
effect of the genotype on the photoreceptor cell layer thickness over time was confirmed by twoway ANOVA (F(1,259)=61.04, p-value<0.0001). In agreement with the ERG data, we did not
observe significant morphological changes up to 28 days after tamoxifen injection (Figure 2C, D,
and Supplement Figure 2). After day 28 post-injection, we observed progressive degeneration of
the photoreceptor cell layer (Figure 2D, and Supplement Figure 2). Approximately half of the
photoreceptor cells were lost by day 42 post-injection in the knockout retinas, and only one layer
of photoreceptor cells remained at day 113 post-injection (Figure 2C, D, and Supplement Figure
2). We did not observe any significant changes in the inner retina, including the inner nuclear
layer (INL) and the ganglion cell layer (GCL). Our results show that the combined deletion of
Msi1/Msi2 in mature photoreceptors leads to a rapid and progressive decline in the function and
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viability of photoreceptor cells that starts four weeks after depletion of the Musashi proteins.
MSI1 and MSI2 are redundant in the maintenance of mature photoreceptors
To determine if MSI2 plays a dominant role in mature retina, as the developmental
regulation of MSI1 and MSI2 protein expression would suggest, we delete the Msi1 and Msi2
genes individually in mature photoreceptors. We confirmed the photoreceptor-specific loss of
MSI1 and MSI2 protein by immunostaining retinal cross-sections obtained at day 14 post-injection
(Figure 3A, and B). Western blot analysis of retinal lysates showed that tamoxifen injection
required 7 to14 days to ablate the proteins, in agreement with our observation of the double
knockout (Figure 3C). The MSI2 protein level was upregulated 1.4-fold in the Msi1-/- retina
compared to the control; however, the increase did not reach statistical significance at the number
of replicates used (n=3).
Neither Msi1 nor Msi2 single ablation had an effect on retina function (Figure 4A). The
scotopic and photopic ERG responses collected from day 7 to day 230 post injection show that
the response to light of the single Msi1 or Msi2 knockout mice are indistinguishable from the
control animals (Figure 4A, and Supplement Figure 4A, B). Similarly, the histology of the knockout
retinas collected at day 230 post injection does not show signs of degeneration (Figure 4B, C).
These data demonstrate that Musashi proteins are fully redundant in mature photoreceptors.

Binding of Musashi to the downstream proximal intron promotes splicing of alternative
exons
To delineate the transcripts bound by Musashi and the positions on the targets where
Musashi binds, we used enhanced UV Cross-Linking and Immuno-Precipitation followed by high
throughput sequencing of the associated RNA fragments (eCLIP-Seq). The MSI1 and MSI2
proteins are fully redundant in the adult retina, their RNA binding domains are 77% (RRM1) to
92% (RRM2) identical, and the two proteins recognize the same UAG binding site

34,35

. Thus, we

argued that performing the eCLIP-Seq experiment on MSI1 will be sufficient to identify the targets
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for both proteins.
Out of 30,283 transcripts detected by RNA-Seq, 10,161 had at least one eCLIP peak
enriched over input and 7,849 transcripts had eCLIP peaks in the 3’-UTR (Online Supplementary
Table 8). The eCLIP-Seq data shows that MSI1 binds predominantly to the 3’-UTRs of mRNA
(59.7% of binding sites, Figure 5A, C) and to introns of pre-mRNA (32.7% of binding sites, Figure
5A, E). Motif enrichment analysis of the sequence surrounding the eCLIP crosslink sites by
HOMER and MEME software suites identified as enriched motifs centered on a UAG core
(Supplement Figure 5). This result is in agreement with the UAG binding site sequence for the
Musashi proteins derived from in vitro binding and structural studies 34–36. The crosslink frequency
peaks at position -1 relative to the top motif identified by DREME, BUAG, indicated direct binding
of MSI1 (Figure 5B).
Previously we identified a photoreceptor-specific alternative splicing program by
comparing the splicing in wild type retina to that in retina that is devoid of photoreceptor cells due
to knockout of the Aipl1 gene

30

. Motif enrichment analysis suggested a role for the Musashi

proteins in controlling this program and we demonstrated that the splicing of at least one exon,
exon 2A in the Ttc8 gene, is activated by MSI1 bound to the downstream intron 30. Here we sought
to determine on a global scale how the Musashi proteins are regulating alternative splicing in
photoreceptor cells in vivo. Analysis by RNA-Seq of alternative splicing in Msi1-/-/Msi2-/- retina 21
days after tamoxifen injection identified 165 exons that had reduced inclusion levels and 115
exons that were upregulated in the knockout (Online Supplementary Tables 1, 2, and 3). Out of
the 165 exons downregulated in the Msi1/Msi2 knockout, 52 were also significantly
downregulated in the photoreceptor-devoid retina of the Aipl1 knockout mice, with another 40
exons showing the same direction of change but not reaching statistical significance in the Aipl1
knockout retina (Online Supplementary Table 2)

30

. None of the significantly downregulated

exons in the Msi1/Msi2 knockout retina were significantly upregulated in the Aipl1 knockout
(Online Supplementary Table 3). We did not observe a correlation between the exons significantly
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upregulated in the Msi1-/-/Msi2-/- retina and the exons differentially spliced in the Aipl1 knockout
retina.
Our previous work suggested that the Musashi proteins promote inclusion of alternative
exons by binding downstream of the exon in the adjacent intron. To determine if this mode of
regulation is common in vivo we combined the eCLIP-Seq and RNA-Seq data to build an RNA
splicing map of a meta cassette exon (Figure 5D). The splicing map shows significant enrichment
of Musashi protein binding to the downstream introns proximal to the exons upregulated by the
Musashi proteins (exons downregulated in the knockout). No significant enrichment of Musashi
binding sites was observed for exons repressed in the wild type animals compared to the Musashi
knockouts.
Photoreceptor-specific microexons in the Ttc8, Cep290, Cc2d2a, Cacna2d4 and Slc17a7
genes are dispensable
Considering the requirement of Musashi proteins for vision and their role in promoting
splicing of photoreceptor specific exons, we next tested if photoreceptor-specific alternative
splicing variants are required for vision. Using CRISPR/Cas 9 we deleted photoreceptor-specific
exons in the Ttc8, Cep290, Cc2d2a, Cacna2d4 and Slc17a7 genes 30. The exons in Ttc8, Cep290,
Cc2d2a and Cacna2d4 genes are microexons, 30nt or less in length, showing sequence
conservation across vertebrates that is traceable to fish (Supplement Figure 6A). We further
confirmed by RT-PCR that the four alternative exons are used in zebrafish and are included at
high rate in the zebrafish eye (Supplement Figure 6B). The photoreceptor-specific exon in
Slc17a7 is confined to rodents and serves as a control representing an evolutionary novel exon
that is less likely to impact the function of the host protein. The exons in the Ttc8, Cep290, Cc2d2a
and Slc17a7 genes were downregulated in our Msi1/Msi2 double knockout mice. Deletion of each
exon was confirmed by sequencing the alleles after the founders have been outcrossed
(Supplement Figure 7). RT-PCR from retinal samples showed the expected expression of exon
skipped isoform (Figure 6A).
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We examined the visual function of the exon knockout mice by ERG between one and
twelve months of age. We did not observe significant differences in the response to light of the
exon knockout mice compared to wild type controls (Figure 6B). Similarly, H&E stained retinal
sections from the exon knockout mice had normal morphology (Figure 6C). The phenotypes of
the individual exon knockout mice may have been too subtle to detect on their own. Thus, we
crossed the Ttc8, Cep290, and Cc2d2a exon knockouts to create a homozygous triple exon
knockout mouse line. As all three proteins are part of the primary cilium and are critical for cilium
biogenesis, we expected the individual exon knockout phenotypes to be amplified in the combined
knockout. As with the single exon knockout mice we did not observe changes in the function or
morphology of the retina of the triple exon knockout animals (Figure 6B and C).
MSI1 and MSI2 are post-transcriptional activators of protein expression in photoreceptor
cells.
Consistent with the previously described role of the Musashi proteins in regulating mRNA
translation, our CLIP-seq data showed pervasive binding of MSI1 to 3’-UTRs (Figure 5A and C).
To determine the effect of Musashi on the protein expression, we analyzed the changes in mRNA
and protein levels in Msi1-/-/Msi2-/- retina where both MSI1 and MSI2 were depleted from mature
photoreceptor cells. For RNA-Seq and quantitative proteomics, we used retinas that were
collected 21 days after tamoxifen injection. At this time the Musashi proteins were depleted from
photoreceptor cells, while the knockout retina had normal morphology and response to light
(Figure 2). Thus, the effect of mRNA and protein expression could be analyzed without the
confounding effects of photoreceptor cell death.
We used isobaric labeling and mass spectroscopy to compare the expression of 8021
proteins in knockout and control retina. Of these proteins 165 showed significant differences in
expression (at least 1.5-fold change in protein levels with adjusted p-value at or below 0.01)
between the control and knockout retina. Of the proteins with significant changes 98 had reduced
expression and 67 had elevated expression in the knockout retina (Online Supplementary Table
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4). As expected, MSI1 and MSI2 protein levels were decreased by more than 2-fold in the retina
of the Msi1/Msi2 knockout mice (Online Supplementary Table 4 and Supplement Figure 8),
consistent with the change in expression observed by western blot (Figures 1, and Supplement
Figure 9). Gene Ontology and KEGG pathway enrichment analysis showed that proteins
downregulated in the knockout retina were strongly associated with categories related to
phototransduction, photoreceptor cell structure, and photoreceptor homeostasis (Figure 7,
Supplement Figure 9, and Online Supplementary Table 5). The reduced expression of proteins in
these categories is not a consequence of photoreceptor cell death or degeneration for two
reasons. First, morphologically and physiologically, the retina of the knockout animals are normal
at this stage. More importantly, the levels of multiple proteins that are specific to photoreceptors
or are abundantly expressed in photoreceptor cells were unchanged or even increased (Figure
7). Examples include proteins with functions in phototransduction (RCVRN), outer segment
structure (PRPH2, PROM1), primary cilium structure (CC2D2A, CEP290), intraflagellar transport
(IFT80, IFT140), ion transport (ATP1B2), and protein transport (RD3).
In contrast to the downregulated proteins, most of the proteins with increased expression
in the knockout retina were associated with Gene Ontology terms and KEGG pathways involved
in cell proliferation, extracellular matrix structure, immune response, and angiogenesis (Online
Supplementary Table 5). Closer examination of the upregulated proteins revealed proteins
(GFAP, CLU, STAT3, JUNB, IRF9, A2M, B2M, complement components) that are expressed at
elevated levels across various models of retinal degeneration 37,37–40. Single cell RNA-Seq of the
Cwc27fs model of retinal degeneration indicated that many of the upregulated genes are
expressed by glia

37

. To determine how MSI1 and MSI2 regulate protein expression in

photoreceptor cells, we defined two sets of genes. The first set were genes that are either
specifically expressed in photoreceptor cells or have at least two-fold higher expression in
photoreceptors compared to any other cell type in the retina. The second set contained genes
that are either not expressed in photoreceptor cells or have at least two-fold lower expression
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compared to other retinal cell types. The two sets of genes were derived from differential
expression analysis of single cell RNA-Sequencing data by Macosco et al

41

. We will use

“photoreceptor-specific” as a shorthand for the subset of genes highly expressed specifically in
photoreceptor cells, with the understanding that many of these genes are also expressed in other
cell types, albeit at lower levels. Most proteins with significantly lower expression in the Msi1-//Msi2-/- retina and without a significant change in their mRNA levels, belonged to the
photoreceptor-specific set of genes (Figure 8A and Online Supplementary Table 7). Only two
photoreceptor-specific proteins, PROM1 and IMPG2, had markedly higher expression in the
knockouts (Figure 8A). All 39 proteins with altered expression derived from “photoreceptorspecific” genes (blue rombs on Figure 8A) contained MSI1 eCLIP peaks in their 3’-UTRs. A
cumulative plot of the changes in protein and RNA expression from the photoreceptor-specific
genes shows a global trend in reduced protein levels that were not matched by a corresponding
decrease in transcript levels (Figure 8B). Taken together our data demonstrates that the Musashi
proteins promote protein expression post-transcriptionally.
MSI1 promotes translation of recombinant Gnat1
To demonstrate a direct activation of protein expression by Musashi we examined the
effect of MSI1 on protein expression from Gnat1 clones carrying full length 3’-UTR in a
heterologous system, NIH 3T3 cells. The NIH 3T3 cells were chosen for the low levels of
endogenous MSI1 and MSI2 protein expression. We created Gnat1 clones that contained either
wild type 3’-UTR or a mutant 3’-UTR in which the TAG sites were changed to TGA to prevent
Musashi binding. The wild type and mutant clones carried HA and T7 epitope tags, respectively.
The clones were mixed together in equal amounts and co-transfected in NIH 3T3 cells with vectors
expressing either GFP, Pcbp2, or Msi1. PCBP2 is a RNA binding protein that like MSI1 and MSI2
is abundantly expressed in photoreceptors, shuttles between the nucleus and the cytoplasm, and
regulates splicing and translation

42,43

. The products of the wild type and mutant clones were

distinguished by the HA (wild type) and T7 (mutant) epitope tags (Figure 8C and D). The epitope
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tags were detected by antibodies on Western blot or by hydrolysable probes in multiplexed RTqPCR, to measure protein and mRNA expression respectively. The effect of the co-transfected
constructus on Gnat1 expression was measured as the change in the ratio of the HA to the T7
signal.
One-way ANOVA found a significant effect of the co-transfected expression vector on the
HA/T7 GNAT1 protein ratio (F(2,15)=50.85, p-value=2.08*10-7). Tukey HSD post-hoc test showed
that MSI1 has a significant (p-value<1*10-7) effect on the GNAT1 protein expression compared to
the vectors expressing GFP or PCBP2 (Figure 8C and D). The analysis of the Gnat1 mRNA levels
also revealed a significant effect of the co-transfected expression construct (one-way ANOVA
F(2,15)=8.19, p-value=0.004). The observed effect was due to a marginal increase in Gnat1
transcript levels in response to MSI1 compared to GFP (Figure 8D). The two-fold increase in
GNAT1 protein expression without a corresponding increase in transcript levels recapitulates the
regulation of GNAT1 by Musashi that we observed in photoreceptor cells and points to a role for
the Musashi proteins as activators of translation.

2.5 Discussion
MSI1 and MSI2 are essential and redundant in mature photoreceptor cells
Here we demonstrate that MSI1 and MSI2 are critical for photoreceptor function and
survival. Disruption of the two genes resulted in rapid loss of vision and retinal degeneration
(Figure 2 and Supplement Figure 2). The Musashi proteins were fully redundant in mature
photoreceptors and the single Msi1 or Msi2 knockouts did not have detectable phenotypes. It is
unclear why Msi1 and Msi2 were only partially redundant during retinal development while they
were fully redundant in mature photoreceptor cells.
While hundreds of mutations in dozens of genetic loci lead to loss of vision, to date no
vision defects have been associated with mutations in the Msi1 and Msi2 genes despite their
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critical function in photoreceptor cells. The lack of disease-causing mutations associated with the
Musashi genes is likely a combination of their redundancy and their critical role in stem cell
maintenance. The redundancy of the two proteins ensures that mutations in one of the genes will
be complemented by the other. At the same time, loss of both Msi1 and Msi2 will result in
embryonic lethality and preempt the observation of retinal phenotypes.
MSI1 and MSI2 activate the inclusion of alternative exons in vivo
Photoreceptor cells express a distinct splicing program that utilizes a large number of
microexons. Motif enrichment analysis suggested that the inclusion of photoreceptor-specific
exons is driven by the Musashi proteins

30

. Recent studies on mouse tissues, flow sorted retinal

cells, and human retinal organoids showed a similar photoreceptor-specific splicing program
directed by Musashi

42,44

. Here we demonstrate that in photoreceptors the Musashi proteins

directly promote the splicing of alternative exons by binding to the downstream intron. The
Musashi proteins promoted the inclusion of more than half of the exons we previously defined as
photoreceptor specific

30

. This leaves a sizable population of photoreceptor-specific exons that

rely on other factors for their splicing. Recent studies have highlighted two such factors, PCBP2
and SRRM3, that can either act independently or cooperate with Musashi to promote splicing of
alternative exons in photoreceptors 42,45.
In addition to the exons activated by the Musashi proteins, a comparable number of exons
appeared to be repressed by them. The repressed exons lack enrichment of MSI1 binding to them
or to the adjacent introns when compared to alternative exons that are not regulated by Musashi.
It is possible that the Musashi proteins have more than one mode of directly repressing splicing
and our dataset does not have sufficient power to detect these interactions as enriched. It is also
likely that many of the repressed exons are not direct targets of the Musashi proteins but are
regulated by factors whose expression is controlled by MSI1 and MSI2. For example, the Musashi
proteins negatively regulate the expression of SRSF9 (Online Supplementary Table 4).
Consequently, the splicing of exons dependent on SRSF9 will be repressed indirectly by the
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expression of the Musashi proteins in photoreceptors.
Dispensable conserved microexons
Use of alternative microexons is a hallmark of the nervous system. The majority of these
alternative exons are conserved which has led to the conclusion that they are essential in neurons.
For several microexons such essential function has been demonstrated using animal knockout
models

12,46–48

. We reasoned that exons that are conserved in vertebrates and are specifically

used in photoreceptor cells will likely have an important role in vision. We deleted four such
conserved exons in the Ttc8, Cep290, Cc2d2a and Cacna2d4 genes, and one exon in the Slc17a7
gene that is present only in rodents and is potentially nonessential (Supplement Figure 7). All five
exons are photoreceptor-specific and are included in nearly all of the transcripts from the
corresponding genes in photoreceptor cells

30,42

. The genes hosting four of the exons, Ttc8,

Cep290, Cc2d2a and Cacna2d4, are essential for vision 49–52. To our surprise the exon knockout
animals did not show a detectable phenotype. A triple knockout of the exons in Ttc8, Cep290,
and Cc2d2a, all essential components of the cilium, also lacked an adverse phenotype. The
absence of phenotype in our exon knockout animals raises questions about the nature of the
selective pressures that have led to the conservation of these exons. It is possible that the
selective pressures are exerted by factors that are absent from the environment under which
laboratory mice are reared. An alternative explanation is that these exons do not have function
and do not alter the properties of the proteins. The conservation of such functionally neutral exons
will be due to purifying selection that eliminates mutations negatively affecting the function of the
host protein and tolerates wholesale deletion of the exon. In support of this model, the
photoreceptor-specific exons in Ttc8 and Cc2d2a are absent from several species (Supplement
Figure 6). Regardless of the conservation mechanism, our results caution against using sequence
conservation as a sole indicator of function.
MSI1 and MSI2 promote protein expression in photoreceptor cells.
The effect of the Musashi proteins on protein translation is context dependent. In flies and
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cultured mammalian cell lines the Musashi proteins repress translation of Numb and p21Waf1/Cip1,
while in frog oocytes they activate early translation of Mos and Cyclin B5 after progesterone
stimulation 21,26,53,54. Furthermore, recent genome wide studies integrating ribosome profiling and
RNA binding data showed that within the same cell MSI1 and MSI2 repress translation of certain
transcripts while activating others 55,56. The transcriptome-wide studies also show that translation
of relatively few of the large numbers of transcripts that are bound by the Musashi proteins is
affected when the levels of MSI1 and MSI2 are manipulated 56.
Here we present an integrative analysis of the effect of MSI1 and MSI2 on protein
translation in photoreceptor cells. To isolate the signal derived from photoreceptor cells, we
focused our analysis on transcripts highly expressed in photoreceptors compared to other retinal
cells and relied on the fact that photoreceptor cells are the dominant cell type in the retina
comprising approximately half of the cells in that tissue. As we are excluding from our analysis
transcripts that are expressed in other cells of the retina at levels comparable to those in
photoreceptors, we derived a broad but far from comprehensive picture of the effect of MSI1 and
MSI2 on the transcriptome and proteome of photoreceptor cells. The amount of material required
for RNASeq, mass-spectrometry, and eCLIP-Seq experiments did not allow us to perform the
experiments in parallel on samples from the same animal. Samples from different animals were
used for each experiment. While there is an excellent correlation across replicates, it should be
noted that changes in protein and RNA expression were not determined within the same animal.
We demonstrate that the combined deletion of Msi1 and Msi2 alters protein expression
from a set of transcripts without significantly affecting the levels of these transcripts. In agreement
with the previously published transcriptome-wide studies, our integrative analysis shows that the
levels of relatively few proteins are affected in the Musashi knockout mice, compared to the
thousands of transcripts bound by MSI1 at their 3’-UTRs.
In photoreceptors, the Musashi proteins act largely to promote protein expression.
Furthermore, the translation of at least one of the targets identified in this work, Gnat1, is directly
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stimulated by MSI1 in a heterologous system. We observed only two cases, PROM1 and IMPG2,
where the combined knockout of Msi1 and Msi2 resulted in elevated protein levels. This is an
unexpected finding in light of the canonical view of the Musashi proteins as repressors of
translation. As the Musashi proteins are regulating both pre-mRNA splicing in the nucleus and
protein expression in the cytoplasm there are some genes affected by both modes of regulation,
e.g. Prom1, raising the question of potential coordination between pre-mRNA splicing and protein
expression. We do not see evidence for such coordination in our data.
The proteins regulated by MSI1 and MSI2 are central to the function and survival of
photoreceptor cells. They include the products of a number of genes that are commonly mutated
in blinding disease (GNAT1, CNGA1, PRCD, ROM1, AIPL1, PDE6A, etc). Photoreceptor cells
need to produce high levels of these proteins in order to replace their outer segments every 10
days. This renewal process does not reuse proteins already present in the outer segment.
Instead, new membranes and proteins are delivered to the bottom of the outer segment stack,
while old segments are phagocytosed and digested by retinal pigmented epithelium from the top
of the stack. Reduced rate of production of outer segment proteins and the chaperones that fold
them will impede the outer segment renewal process leading to loss of vision and degeneration
of the photoreceptor cells.

2.6 Materials and Methods
Animals
All animal experiments were conducted with the approval of the Institutional Animal Care
and Use Committee at West Virginia University. Both males and females were used in all
experiments. The mouse lines in this study were in the C57BL6/J background and devoid of the
naturally occurring rd1 and rd8 alleles. The mice were genotyped at weaning unless otherwise
specified in the results section. The primers used for genotyping of the targeted alleles are listed
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in Online Supplementary Table 14.
Mice carrying Msi1

flox/flox

and Msi2

flox/flox

were provided by Dr. Christopher Lengner from

the University of Pennsylvania (Li et al., 2015; Park et al., 2014). Mice carrying the floxed alleles
were crossed with Pde6g-CreERT2 mice to enable photoreceptor-specific conditional knockout of
Msi1 and Msi2 (Koch et al., 2015). The conditional deletion of Msi1 and Msi2 in mature
photoreceptor cells was induced by intraperitoneal injection of tamoxifen in corn oil (Sigma-Aldrich
catalog #T5648-1G) at concentrations of 100 mg/kg body weight for three consecutive days.
The knockouts of the photoreceptor specific exons in Ttc8, Cep 290, and Cc2d2a were
created using CRISPR/Cas9. Two guide RNAs targeted at sites upstream and downstream of
each alternative exon were used to cause full deletion of the exon and the proximal parts of the
introns. The guide RNAs were synthesized by Synthego and IDT. The guide RNA targeting
sequences are listed in Online Supplementary Table 13. The guide RNAs and Cas9 (Thermo
Fisher) were assembled into ribonucleoprotein complexes and electroporated into zygotes by the
WVU transgenic core facility. The founders were back-crossed to C57BL6/J mice (Jackson
Laboratory) for 5 generations. To map the borders of the deletions, the exon knockout alleles
were amplified by PCR using the genotyping primers and sequenced by Sanger sequencing
(Supplement Figure 7). Frozen sperm for each line is available from the authors upon request.
Adult zebrafish (Danio rerio) animals were maintained at 28°C with standard 14/10
light/dark cycles. For dissections, we used adult Tubingen long-fin strain (approximately 22
months old). Equal female and male zebrafish were euthanized in an ice bath of system water
until the termination of buccal and gill motion. Tissue dissection was performed in physiological
saline E3h media (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, and 1 mM
HEPES, pH 7.3). Collected samples were immediately collected in centrifuge tubes and frozen.
Clones, cell lines, and transfection
A full length Gnat1 clone (accession BC058810) was obtained from Horizon Discovery
and recloned in pcDNA3.1(+) (Invitrogen). A matching clone in which all 16 TAG triplets in the
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1.11kbp 3’-UTR were mutated to TGA to disrupt the Musashi binding sites was created using
gene synthesis (Genscript). Gibson assembly was used to reclone the cDNAs into pcDNA3.1(+)
vector and attach HA- and T7-tags to the wild type and mutant clone, respectively. Full length
Msi1 clone with N-terminal Flag epitope tag in pcDNA3.1 was described before

30

. Full length,

codon optimized mouse Pcbp2 clone with N-terminal Flag epitope tag was produced by gene
synthesis (Genscript) and cloned in pcDNA3.1(+) (Invitrogen). All clones are available from
Addgene (https://www.addgene.org/Peter_Stoilov/).
NIH 3T3 cells were grown in DMEM supplemented with 10% Fetal Bovine Serum. The
cells were maintained in a humidified incubator at 37°C in 5% CO2 atmosphere. Transfection with
polyethyleneimine was carried out as described before 57. Briefly, the 6 hours prior to transfection
the cells were seeded at 3.2*105 cells per well in 6 well plates. A total of 500 ng of DNA was used
per transfection, containing 125 ng of each wild type and mutant Gnat1 construct, and 250 ng of
expression vector that carried a flag-tagged EGFP, Pcbp2 or Msi1 clone in pcDNA3.1(+)
backbone. The cells were collected 27 to 29 hours post-transfection to analyze protein and mRNA
expression.
RNA extraction and RT-PCR
RNA was extracted with Trisol and precipitated with isopropanol. The RNA was then
dissolved and treated with RNAse-free DNase I (Roche) for 20 minutes at 37°C. After DNA
digestion the reactions were extracted once with chloroform and the RNA was precipitated with
ethanol. RT-PCR analysis of alternative splicing using fluorescently labeled primers was
described before 30,58.
The levels of Gnat1 transcripts expressed from the recombinant clones in 3T3 cells were
determined by multiplexed RT-qPCR. Hydrolysis probes to the HA and T7 tags were used to
detect Gnat1 transcripts with wild type and mutant 3’-UTRs, respectively. The RT-qPCR was
performed using Luna One Step RT-qPCR mix with dUDG (NEB). Amplification using Luna One
Step qPCR mix with UDG (NEB) that did not contain a reverse transcriptase component (NEB)
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served as no-reverse -transcriptase controls for DNA contamination. The ratio of the transcript
levels measured by the HA and T7 probes was used to determine the effect of each treatment on
the mRNA levels expressed from the constructs carrying wild type and mutant 3’-UTRs. The
primers and probes used for alternative splicing and RT-qPCR analysis are listed in Online
Supplementary Table 14.
Electroretinography (ERG) Measurement and Preparation of Animal
ERGs were measured using either UTAS Visual Diagnostic System with Big-Shot
Ganzfeld device (LKC Technologies, Gaithersburg, MD, USA) or Celeris system with Espion
software (Diagnosis LLC, Lowell, MA, USA). Prior to testing, mice were dark-adapted overnight.
All further handling of mice following dark adaptation was performed under deep red illumination.
The mice were anesthetized by inhalation of 1.5% isoflurane mixed with 100% oxygen at a flow
rate of 2.5 l/min. The pupils were topically dilated with a drop of tropicamide and phenylephrinehydrochloride, allowing drops to sit on both eyes for 10 mins. After that, mice were transferred to
a heated platform connected to a nose cone that allows for a continuous flow of isoflurane. A
reference electrode was inserted sub-dermally between the eyes of the mouse, and ERG
responses were collected from both eyes using wire electrodes placed on the center of each
cornea, with contact being made using a drop of 0.3% Hypromellose solution. To deliver the
stimulus, a Ganzfeld Bowel was used with LED white arrays at increasing intensities. Darkadapted scotopic photoresponse was recorded under the dim red light using a single LED white
light flashes of luminescence ranging from 2.45·10-4 to 2.4 cd-s/m2. For photopic response,
animals were light-adapted for 10 min in the presence of rod-saturating 30 cd-s/m2 ambient white
light prior to recording the photopic response.
Western Blot
Mouse retinas were lysed using RIPA buffer (50 mM Tris HCl-pH 8.0, 150 mM NaCl, 1.0%
TritonX-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate) supplied with protease
(Sigma-Aldrich catalog# 535140-1ML) and phosphatase inhibitors cocktail (Sigma-Aldrich catalog
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# P5726-1 ML). After homogenization, the lysate was incubated on ice for 10 mins, then cleared
by centrifugation for 15 mins. 20 μg of protein extract was resolved in 4-20% polyacrylamide SDS–
PAGE gel and transferred onto polyvinylidene difluoride (PVDF) membranes (Immunobilon-FL,
Millipore). After blocking with BSA in PBST (Phosphate- buffered saline with 0.1% Tween-20), the
membranes were blocked and probed with primary antibodies overnight at 4 °C, followed by
incubation with fluorescently labeled (Alexa Fluor 647 or 488, Jackson ImmnuoResearch)
secondary antibodies for 1 hour at room temperature. The membranes were then scanned on
Amersham Typhoon Phosphorimager (GE Healthcare). GFP protein in transfection samples was
detected by its intrinsic fluorescence in the 488nm channel. To quantify the protein expression
across membranes, the band intensities detected by each antibody were scaled to the median
signal for the membrane. The scaled expression values were then normalized to the scaled values
of the corresponding controls (loading controls or in the transfection experiments to proteins
expressed from co-transfected constructs). The antibodies used for western blot analysis are
listed in Online Supplementary Table 12.
Retinal histology
The whole eyecups from the knockout and control mice were enucleated. The eyes were
then fixed using a Z-fixative (Excalibur Pathology Inc). Tissue processing, including paraffin
embedding and hematoxylin and eosin (H&E) staining, was performed at Excalibur Pathology.
Images of the stained slides were collected using a Nikon Brightfield Microscope operated by
Element software (Nikon). To evaluate the photoreceptor cell loss, we counted the number of
nuclei within the outer nuclear layer (ONL) using the NIS elements software. The counting was
done at ten equidistant locations centered on the optical nerve and moving toward the periphery
in 400 µm increments. Five locations were on the inferior side (-5 to -1) and five on the superior
side (1 to 5) of the retina relative to the optic nerve. For each location and the number of nuclei
reported is the average of 4 technical replicates. The nuclei counts were averaged over 3
biological replicates that represent retinas from three separate animals.
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Immunocytochemistry
Eyes were enucleated, and a small window was cut in the cornea before immersing it in
4% paraformaldehyde fixative (4% PFA in PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
and 1.8 mM KH2PO4, pH 7.2) for 3 hours on a rotator. Eyecups were dehydrated by sequential
incubation in 7.5%, 15%, and 22% sucrose in 1xPBS. Eyecups were then snap-frozen in optimal
cutting temperature compound (OCT) blocks. Serial 16 µm sections were cut on a Leica CM1850
cryostat and mounted onto Superfrost Plus microscope slides (Fischer Scientific). Mounted retinal
sections were washed 3 times for 10 mins each with PBS and then blocked with PBST for 1 hour
(10% goat serum, 0.3% Triton X-100, and 0.02% sodium azide in PBS). Retinal sections were
incubated overnight at 4°C with primary antibodies diluted in PBST supplemented with 5% goat
serum. After three 15 min washes with PBST the sections were incubated for one hour with
secondary antibodies diluted 1:1000 in PBST supplemented with 5% goat serum and 4′,6diamidino-2-phenylindole. The sections were washed three times for 15 min with PBST, mounted
with Prolong Antifade reagent (Thermofisher), and secured with coverslips. The sections were
imaged on a Nikon C2 laser scanning confocal microscope. The laser power, gain, and offset
settings were maintained the same when imaging sections from knockout and control littermates.
The antibodies used for immunofluorescence staining are listed in Online Supplementary Table
12.
RNA sequencing
Total RNA was isolated at day 21 post tamoxifen injection using Tri-reagent (Sigma) from
retinas in four biological replicates of Msi1+/+/Msi2+/+ and Msi1-/-/Msi2-/- mice. Sequencing libraries
were prepared by the West Virginia University genomics core using KAPA Hyper RNA with
Riboerase (Roche). The libraries were sequenced by the University of Illinois DNA services core
on Illumina HiSeq 4000 at an average depth of 44 million 100nt paired end reads.
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RNA-Seq reads were aligned to the mouse genome (GRCm38) using HISAT2

60

. The

mapped reads were summarized using Rsubread, and differential gene expression analysis was
carried out by edgeR (Online Supplementary Table 8)

61,62

. Inclusion levels of cassette exons

were calculated by rMATS (4.1.0), using reads spanning exon-exon junctions 63.
CLIP-sequencing and meta-exon analysis
The rabbit anti-MSI1 (1:1000; catalog# ab 52865, Abcam, Cambridge, MA) was used for
eCLIP. Briefly, retinas from wild-type mice (80 mg per replicate) were collected and placed in icecold PBS in a 10 cm2 plate. Plates containing retinas were then placed on ice and UV-crosslinked
(254 nm, 200 mJ/cm2 ) using UV StratalinkerTM 2400. UV-crosslinked retinas were then snap
frozen in liquid nitrogen. Further tissue processing, eCLIP library prep, and sequencing were
carried out by Eclipse Bioinnovations following a previously published protocol

64

. The raw data

obtained from the eCLIP-Seq are available at the NCBI Sequence Read Archive under project
accession PRJNA795195.
To analyze the raw eCLIP data, the adapter sequences were first trimmed using cutadapt
65

. HISAT2 was used to map the reads to version GRCm38 of the mouse genome and the mapped

reads were deduplicated by umi-tools using the unique molecular identifier (UMI) barcodes built
into the adapters

60,66

. Crosslink sites were identified and clustered (Supplemental data set 1)

into regions using PureClip 67. Motifs enriched in the 51 nucleotide sequence fragments centered
on the crosslink sites were identified by HOMER and DREME 68,69.
Meta-exon analysis was performed using the RBP-maps software package on nonredundant sets of alternatively spliced exons identified in our RNA-Seq analysis of Msi1/Msi2
double knockout in photoreceptor cells

70

. The distribution of MSI1 crosslinks around exons

downregulated or upregulated in the photoreceptor-specific Msi1/Msi2 double knockout was
compared to alternative exons that were not affected by the knockout (Online Supplementary
Tables 9, 10, and 11). 1000 random permutations of the non-regulated exon set were used to
determine the 99.5% confidence intervals as described by Yee at al 70.
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Proteomics analysis
Retina samples from Msi1+/+/Msi2+/+ and Msi1-/-/Msi2-/- were collected 21 days after
tamoxifen injections. Five biological replicates were used for each wild-type and knockout group.
Tissue processing and proteomics quantification of snapped frozen retina samples was performed
by

IDeA

proteomics.

Briefly,

proteins

were

reduced,

alkylated,

and

purified

by

chloroform/methanol extraction prior to digestion with sequencing-grade modified porcine trypsin
(Promega). Tryptic peptides were labeled using tandem mass tag isobaric labeling reagents
(Thermo) following the manufacturer’s instructions and combined into one 10-plex sample group.
The labeled peptide multiplex was separated into 46 fractions on a 100 x 1.0 mm Acquity BEH
C18 column (Waters) using an UltiMate 3000 UHPLC system (Thermo) with a 50 min gradient
from 99:1 to 60:40 buffer A:B ratio under basic pH conditions, and then consolidated into 18 superfractions. Each super-fraction was then further separated by reverse phase XSelect CSH C18 2.5
um resin (Waters) on an in-line 150 x 0.075 mm column using an UltiMate 3000 RSLCnano
system (Thermo). Peptides were eluted using a 60 min gradient from 98:2 to 60:40 buffer A:B
ratio. Eluted peptides were ionized by electrospray (2.2 kV) followed by mass spectrometric
analysis on an Orbitrap Eclipse Tribrid mass spectrometer (Thermo) using multi-notch MS3
parameters. MS data were acquired using the FTMS analyzer in top-speed profile mode at a
resolution of 120,000 over a range of 375 to 1500 m/z. Following CID activation with normalized
collision energy of 35.0, MS/MS data were acquired using the ion trap analyzer in centroid mode
and normal mass range. Using synchronous precursor selection, up to 10 MS/MS precursors
were selected for HCD activation with normalized collision energy of 65.0, followed by acquisition
of MS3 reporter ion data using the FTMS analyzer in profile mode at a resolution of 50,000 over
a range of 100-500 m/z. Buffer A is 0.1% formic acid, 0.5% acetonitrile; Buffer B is 0.1% formic
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acid, 99.9% acetonitrile. Both buffers were adjusted to pH 10 with ammonium hydroxide for offline
separation.
To create a database of proteins expressed in the retina, we first filtered our mouse retina
RNA-Seq data to remove genes with median expression across all samples that were below the
median expression for the dataset. As a result, we selected 15,626 genes with expression equal
or more than 1.2 RPKM. Ensembl release 79 was queried for annotated proteins produced by
these genes resulting in a database of 34,055 protein sequences. Peptide identification against
the retinal protein database was performed using MS-GF+ (version v2021.03.22) with parent ion
tolerance of 10 ppm, reporter ion tolerance of -0.00335 Da, and +0.0067 Da, and requiring fully
tryptic peptides 71. Only peptides with peptide level Q-value of 0.05 or below were accepted. The
MSnbase package from R/Bioconductor was used to quantify the MS3 reporter ions and combine
the identification and quantification data

72,73

. Differential protein expression analysis was

performed using the DeqMS package from R/Bionconductor 74. Protein changes with adjusted pvalue below 0.05 and fold change of more than 1.5 were considered significant.
WebGestalt (WEB-based Gene SeT Analysis Toolkit) was used to perform enrichment
analysis on the Gene Ontology and KEGG databases for the proteins with significant changes in
gene expression. Only terms enriched at FDR<0.05 were reported 75.
Experimental design and Statistical analysis
Age-matched males and females in the C57BL6/J background were used in all
experiments. The statistical analysis and data visualization was done using GraphPad Prism and
R/Bioconductor. Unpaired Student's t-test was used to assess statistical significance between
control and knockout samples. Statistical significance was determined with one-way or two-way
ANOVA followed by pairwise comparisons as indicated in the text. All data were presented as the
mean ±standard error of the mean.
Data availability
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The eCLIP-Seq and RNA-Seq data are available at the NCBI Sequence Read Archive
under project accessions PRJNA795195 and PRJNA795137.

The mass spectrometry

proteomics are deposited to the ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identifier PXD030748 and 10.6019/PXD030748 76,77.
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2.10 Figures

Figure 2-1 Induced double knockout of Msi1 and Msi2 in photoreceptor cells

Figure 1. Induced double knockout of Msi1 and Msi2 in photoreceptor cells. A)
Immunofluorescence micrographs of retinal cross-sections collected 14 days after tamoxifen
injection at postnatal day 30 from Msi1+/+/Msi2+/+ littermate control and Msi1-/-/Msi2-/-, stained for
MSI1(green), MSI2 (magenta), and DAPI (blue). ONL: outer nuclear layer (photoreceptor cell
layer). INL: inner nuclear layer. GC: ganglion cell layer. Objective, 40x. B) Immunoblot of lysates
from Msi1+/+/Msi2

+/+

and Msi1-/- /Msi2-/- retinas collected between 0 and 70 days after tamoxifen

injections at postnatal day 30 and probed with antibodies to MSI1, MSI2 and TUBB (β-tubulin,
loading control). See Supplement Figure 1 for full size blots.
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Figure 2-2 Progressive loss of function and retinal degeneration after double knockout of Msi1 and Msi2 in photoreceptor
cells

Figure 2. Progressive loss of response to light and retinal degeneration after double
knockout of Msi1 and Msi2 in photoreceptor cells. Time course of scotopic A-wave (A) and
photopic B-wave (B) responses from Msi1+/+/Msi2 +/+ (black line), and Msi1 -/- /Msi2 -/- retinas (red
line) following tamoxifen injection. Scotopic and photopic waveforms were obtained at 0.151
cd*s/m2 and 4.88 cd*s/m2 flashes, respectively. Insets show representative electroretinograms
from a single Msi1+/+/Msi2

+/+

(black line) and Msi1

-/-

/Msi2

-/-

(red line) mouse retina at day 105

post tamoxifen injection. The data points from the scotopic and photopic responses are
represented as mean ± SEM of 8 eyes (4 animals). A pairwise t-test with Bonferroni correction for
multiple comparisons was used to determine the effect of genotype on the A-wave amplitude at
each time point. Significance levels of the pairwise comparisons is indicated as: * p-value < 0.05,
** p-value < 0.01, *** p-value < 0.001. C) Outer nuclear layer degeneration in Msi1-/-/Msi2/-

knockout retinas. Representative H&E-stained sections from the Msi1+/+/Msi2+/+ and Msi1-/-

/Msi2-/- retinas collected between day 0 and day 113 post-tamoxifen injection. ONL: outer nuclear
layer (Photoreceptor nuclei), INL: inner nuclear layer, GC: ganglion cells. 40X objectives and
scale bar represent 50 μm. D) Spider plots displaying the thickness of the ONL as the number of
nuclei measured at ten points stepped by 400µm from the optical nerve at different time points
post-tamoxifen injection. Data are shown as mean ± SEM. A pairwise t-test with Bonferroni
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correction for multiple comparisons was used to determine the effect of the genotype on the outer
nuclear layer thickness at each time point. Significance levels of the pairwise comparisons is
indicated as: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001.

Figure 2-3 Induced single knockouts of Msi1 or Msi2 in photoreceptor cells

Figure 3. Induced single knockouts of Msi1 or Msi2 in photoreceptor cells. . A)
Immunofluorescence micrographs of retinal cross-sections collected 14 days after tamoxifen
injection at postnatal day 30 from Msi1-/- mice and Msi1+/+ littermates (A) or Msi2-/- mice and Msi2+/+
littermates (B). Sections were stained with antibodies to MSI1(green), MSI2(magenta) and DAPI
(blue). ONL: outer nuclear layer (photoreceptor cell layer). INL: inner nuclear layer. GC: ganglion
cell layer. Objective, 40X. C) Immunoblot of lysates from Msi1+/+ and Msi1-/- retinas collected
between 0 and 70 days after tamoxifen injections and probed with antibodies to MSI1, MSI2 and
TUBB (loading control). See Supplement Figure 3 for full size blots.
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Figure 2-4 Normal retinal function and morphology in the single knockouts Msi1 or Msi2 in photoreceptor cells

Figure 4. Normal photoreceptor response to light and retinal morphology in the single
knockouts Msi1 or Msi2 in photoreceptor cells. A) Scotopic mean A-wave response from
single Msi1 -/- (left) or Msi2 -/- (right) knockouts in photoreceptors (red lines) and littermate controls
(black lines) recorded between 0 and 230 days post tamoxifen injection. Scotopic waveforms
were obtained using 0.151 cd-s/m2 flashes. The insets of panels A and B show representative
scotopic (dark-adapted) electroretinograms from a single knockout (red) or control (black) retina
at D230 post-injection using 0.151 cd-s/m2 flashes. Scotopic waveforms were obtained after dark
overnight adaptation using 0.151 cd-s/m2 flashes. B) Representative H&E-stained sections from
retinas of single Msi1

-/-

(left) or Msi2

-/-

(right) knockouts in photoreceptor cells and littermate

controls collected 230 days post-tamoxifen injection. ONL: outer nuclear layer (Photoreceptor
nuclei), INL: inner nuclear layer, GC: ganglion cells. 40X objectives, scale bar, represents 10μm.
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C) Spider plots of ONL thickness for single Msi1

-/-

(left) or Msi2

-/-

(right) knockouts (red) and

littermate controls (black). The plots display the thickness of the ONL as the number of nuclei
measured at ten points stepped by 400µm from the optical nerve in retinas collected 230 days
after tamoxifen injection. Data are shown as mean ± SEM of 8 eyes from 4 animals.
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Figure 2-5 In the retina MSI1 binds to UAG motifs located predominantly in introns and 3’-UTRs

Figure 5. In the retina MSI1 binds to UAG motifs located predominantly in introns and 3’UTRs. A) Distribution of MSI1 binding sites as identified by eCLIP-Seq on mouse retinal samples
across mRNA features. B) eCLIP crosslink frequency relative to the top scoring motif (BUAG)
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identified by DREME. C) UCSC Genome browser tracks showing the eCLIP-seq signal
enrichment over the 3’-UTR of the Gnat1 gene (orange box). Replicates are stacked and indicated
by different shading colors. Scales are 0 to -1155 for the eCLIP IP and 0 to -24 for the eCLIP
input. D) RNA binding protein map showing MSI1 binding relative to an alternative metaexon.
Exons upregulated by the Musashi proteins (downregulated in the Msi1/Msi2 double knockout)
are shown in red, exons downregulated by the Musashi proteins are shown in blue and alternative
exons remaining unchanged in the knockout are shown in black. Gray shading indicates the
99.5% confidence interval derived from 1000 random permutations. MSI1 binding sites are
enriched downstream of alternative exons upregulated by the Musashi proteins. E) UCSC
Genome browser tracks showing MSI1 binding (orange box) downstream of an alternative exon
in the Prom1 gene regulated by the Musashi proteins (green box). RNA-Seq tracks show the read
density for retinal samples derived from photoreceptor-specific Msi1/Msi2 double knockouts and
matched controls. Replicates are stacked and indicated by different shading colors. Scales are 0
to -5.5 for the eCLIP IP and 0 to -1.3 for the eCLIP input.

Figure 2-6 Normal photoreceptor response to light and retinal morphology of knockouts of photoreceptor-specific exons
in the Ttc8, Cc2d2a, Cep290, Cacna2d4, and Slc17a7 genes
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Figure 6. Normal photoreceptor response to light and retinal morphology of knockouts of
photoreceptor-specific exons in the Ttc8, Cc2d2a, Cep290, Cacna2d4, and Slc17a7 genes.
A) RT-PCR of retinal samples showing loss of the photoreceptor-specific mRNA isoforms in the
exon knockout animals. RNA was extracted from the retinas of wild-type animals (WT), and
heterozygous (Het) and homozygous (Null) exon knockouts. Isoforms including and skipping the
alternative exon are indicated by “+” and “-”, respectively. B. Violin plots of the photopic and
scotopic A-wave intensities at postnatal days 30, 150, and 356 were collected from the single and
triple (Ttc8, Cc2d2a, Cep290) exon knockouts. C) Representative H&E-stained retinal sections
from wild-type mice, knockouts of photoreceptor-specific microexons in the Ttc8, Cep290,
Cc2d2a, Canca2d4, and Slc17a7 genes, and combined deletion of the microexons in the Ttc8,
Cep290, Cc2d2a genes. The samples were collected at 12 months of age. ONL: outer nuclear
layer (Photoreceptor nuclei), INL: inner nuclear layer, GC: ganglion cells. 40X objectives, scale
bar, represents 20μm.
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Figure 2-7 Expression of proteins critical for photoreceptor function after induced knockout of Msi1 and Msi2 in
photoreceptor cells

Figure 7. Expression of proteins critical for photoreceptor function after induced knockout
of Msi1 and Msi2 in photoreceptor cells. Boxplots representing the log2 of the fold change in
protein expression relative to the median of the control. Retinal samples were collected 21 days
after inducing the knockout at postnatal day 30. Protein levels were determined using isobaric
labeling and mass-spectroscopy. Boxplots represent a selected set of proteins that are
components of the phototransduction pathway (A), outer segment primary cilium structure (B),
intraflagellar transport complex and BBSome (C), and the inner segment (D). The data is
represented as mean ± SEM of five replicates. Significance level is indicated as: * adjusted pvalue < 0.05, ** adjusted p-value < 0.01, *** adjusted p-value < 0.001. Online Supplementary table
17 contains the source data underlying the graphs.
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Figure 2-8 In photoreceptor cells, MSI1 and MSI2 act to promote protein expression post-transcriptionally

Figure 8. In photoreceptor cells, MSI1 and MSI2 act to promote protein expression posttranscriptionally. A). Scatter plot comparing protein and transcript levels changes after double
Msi1/Msi2 knockout in mature photoreceptor cells. Protein expression was quantified by isobaric
labeling and mass spectrometry. Transcript expression levels were determined by RNA-Seq.
Genes that are highly expressed specifically in photoreceptor cells are shown as rombs and
genes highly expressed outside of photoreceptor cells are shown as crosses. Color indicates
significant changes in protein levels alone (blue), in mRNA levels alone (green), in both protein
and mRNA levels (orange), or no significant change in expression (gray). B) Cumulative
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frequency plots showing the deletion of Msi1/Msi2 in mature photoreceptors leads to broad
decrease of photoreceptor protein levels in excess to changes in transcript levels (KolmogorovSmirnov p-value=1.1*10-12). C) Western blot analysis of recombinant GNAT1 expression in NIH
3T3 cells. Cells were transfected with equal amounts HA-tagged Gnat1 clone with wild type 3’UTR and T7-tagged Gnat1 clone with mutant 3’-UTR that lacks Musashi binding sites. Each
transfection included one of the following: vector expressing flag-tagged GFP, vector expressing
flag-tagged Pcbp2, and vector expressing flag-tagged Msi1. Non transfected cells were included
as a control for the specificity of the antibodies. TUBB serves as loading control. D) Ratios of the
HA (wild type) to T7 (mutant) tagged GNAT1 proteins and ratios of the corresponding RNA
transcripts in the transfected NIH 3T3 cells. The data is represented as mean ± SEM of six
replicates. The statistical significance of the effect of MSI1 in pairwise comparisons to the controls
was determined by Tukey HSD. Significance level is indicated as:* p-value < 0.05, ** p-value <
0.01, *** p-value < 0.001. Online Supplementary table 15 contains the source data underlying the
graph on panel D.
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2.11 Supplementary information

Supplement Figure 2-9 Full-size western blot images for the data presented on Figure 1B

Supplement Figure 1. Full-size western blot images for the data presented on Figure 1B
(blue boxes). Labels on the left indicate the protein being probed. Animal genotypes are indicated
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on the top and the days after tamoxifen injection are indicated at the bottom. Day 0 after tamoxifen
injection corresponds to postnatal day 30.

Supplement Figure 2-10 Outer nuclear layer thickness of the retina after double knockout of Msi1 and Msi2 in
photoreceptor cells

Supplement Figure 2. Outer nuclear layer thickness of the retina after double knockout of
Msi1 and Msi2 in photoreceptor cells. (A) Representative H&E-stained eye sections from the
double Msi1/Msi2 knockout and age-matched controls at 7, 14, 28, and 42 days after inducing
the knockout. ONL: outer nuclear layer (Photoreceptor nuclei), INL: inner nuclear layer, GC:
ganglion cells. 40X objectives and scale bar represent 50 μm. (B) Spider plots displaying the
thickness of the ONL as the number of nuclei measured at ten points stepped by 400µm from the
optical nerve at different time points post-tamoxifen injection. Data are shown as mean ± SEM. A
pairwise t-test with Bonferroni correction for multiple comparisons was used to determine the
effect of the genotype on the outer nuclear layer thickness at each time point. Significance levels
of the pairwise comparisons is indicated as: * p-value < 0.05, ** p-value < 0.01, *** p-value <
0.001.
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Supplement Figure 2-11 Full-size western blot images for the data presented on Figure 1B.

Supplement Figure 3. Full-size western blot images for the data presented on Figure 1B
(blue boxes). Labels on the left indicate the protein being probed. Animal genotypes are indicated
on the top and the days after tamoxifen injection are indicated at the bottom. Day 0 after tamoxifen
injection corresponds to postnatal day 30.
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Supplement Figure 2-12 Normal photopic response to light in the single Msi1 or Msi2 knockouts

Supplement Figure 4. Normal photopic response to light in the single Msi1 or Msi2
knockouts. A) Photopic mean B-wave response of knockout (red) Msi1-/- (A) and Msi1-/- (B) mice
(red line) and age-matched controls (black) between day 16 and day 230 post tamoxifen injection.
Photopic waveforms were obtained after light adaptation using 4.88 cd-s/m2 flashes. The insets
show representative photopic (light-adapted) electroretinograms recorded 230 days post-injection
using 4.88 cd-s/m2 flashes. The data points from the photopic responses of the single depletion
of Msi1 or Msi2 are represented as mean ± SEM of 8 eyes from 4 animals.
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Supplement Figure 2-13 Sequence motifs enriched near eCLIP-Seq derived MSI1 crosslinks sites

Supplement Figure 5. Sequence motifs enriched near eCLIP-Seq derived MSI1 crosslinks
sites. Logos of the top ten significantly enriched motifs identified by DREME (A) or HOMER (B)
in the vicinity of MSI1 crosslink sites.
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Supplement Figure 2-14 Conservation of the photoreceptor-specific exons of Ttc8, Cc2d2a, Cep290, Cacna2d4, and
Slc17a7 across vertebrates

Supplement Figure 6: Conservation of the photoreceptor-specific exons of Ttc8, Cc2d2a,
Cep290, Cacna2d4, and Slc17a7 across vertebrates. (A) Alignments showing the alternative
exons and parts of the flanking constitutive exons. Introns are in lower case, and exons are in
upper case. Forward slashes indicate where intronic sequences were removed from the alignment
for ease of presentation. Homologous exons for the photoreceptor-specific exons in Ttc8, Cc2d2a,
Cep290, and Cacna2d4 can be traced down to Chondrichthyes. The exons in Ttc8, and Cc2d2a
can vary in length while preserving the reading frame or be completely absent from certain
species. The upstream exon is not available for Chrysemys picta due to gaps in the genome
sequence. The exon in Slc17a7 is present only in rodents. (B) Analysis of the inclusion rate of the
zebrafish homologues of the photoreceptor-specific exons in the Ttc8, Cc2d2a, Cep290, and
Cacna2d4 in brain, muscle, and eye samples. Numbers under the figure indicate the percent
inclusion of the exon ± SEM. All four exons have high inclusion rates in the eye. Unlike their
mouse homologues the zebrafish exons in the Cc2d2a and Cacna2d4 genes are also included at
high rate in the brain and muscle, respectively. *The exon in Cacna2d4 was typically included at
100% (3 out of 4 tested samples).
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Supplement Figure 2-15 Exon deletion alleles generated by CRISPR/Cas9 mutagenesis

Supplement Figure 7. Exon deletion alleles generated by CRISPR/Cas9 mutagenesis. A)
Schematic of the CRISPR/Cas9 targeting strategy. Two guide RNAs are used to direct cuts on
both sides of the exon leading to its deletion. (B) Sequences of the knockout alleles (KO) aligned
to the wild-type genomic sequence (WT). The exons are shown in uppercase, and introns are in
lowercase. Arrows indicate the position and orientation (5’ to 3’) of the guide RNAs.
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Supplement Figure 2-16 Decrease of MSI1 and MSI2 protein levels in the retina after induced double knockout of Msi1
and Msi2 in mature photoreceptor cells

Supplement Figure 8. Decrease of MSI1 and MSI2 protein levels in the retina after induced
double knockout of Msi1 and Msi2 in mature photoreceptor cells. A) Box plot showing the
distribution of normalized signal intensities across samples analyzed by isobaric labeling and
tandem MS (MS3). B) Box plots showing the log2 of the fold difference of MSI1 and MSI2 protein
levels in the retina of control and knockout mice relative to the median of the controls. Changes
in the levels of individual tryptic peptides identified for MSI1 (C) and MSI2 (D) in control and
knockout retina.
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Supplement Figure 2-17 Validation of MS3 data by western blot

Supplement Figure 9. Validation of MS3 data by western blot. A) Representative immunoblot
showing levels of selected proteins after combined deletion of Msi1 and Msi2 in mature
photoreceptors. B) Quantification of western blot data for MSI1, MSI2, GNAT1, GNB1, and
PROM1. TUBB1 and GAPDH were used as controls to normalize for loading. Error bars represent
standard error of the mean (SEM, n=3). The statistical significance of the pairwise comparisons
of the protein levels at different time points to the baseline level at the day of the tamoxifen
injection is indicated as: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001.
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Supplement Figure 2-18 Full size blots for data presented in figure 8C
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Supplement Figure 10. Full size western blot images for the data presented on Figure 8C
(blue boxes). Labels on the left indicate the protein being probed. The transfected samples
include the construct indicated on the top along with expression constructs for HA-Gnat1 with wild
type 3’-UTR and T7-Gnat1 with mutant 3’-UTR.
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3. Chapter 3
3.1 TITLE: The 13A4 monoclonal antibody to the mouse PROM1 protein
recognizes a structural epitope
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Note: This chapter include text and figures taken from the publications highlighted above
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3.2 Abstract
Purpose: We endeavored to map the epitope of the rat monoclonal antibody mAB 13A4 to the
mouse PROM1 (CD133, AC133) protein. mAB 13A4 is the main reagent used to detect the
mouse PROM1 protein. PROM1 is required for the maintenance of primary cilia and mutations
in the Prom1 gene are associated with retinal degeneration.
Methods: Epitope-tagged clones of splice variants and tiled deletion mutants were used to map
the mAB 13A4 epitope and test the predicted tertiary structure of PROM1. The proteins were
expressed in Neuro 2a cells and analyzed by Western blot with antibodies to PROM1 and the
epitope tag.
Results: Deletions in the second and third extracellular domains of the PROM1 protein disrupted
the mAB 13A4 epitope. Furthermore, the affinity of mAB 13A4 to the major PROM1 isoform in
photoreceptor cells is significantly reduced due to the inclusion of a photoreceptor-specific
alternative exon in the third extracellular domain. Interestingly, a deletion in the photoreceptorspecific isoform of six amino acids adjacent to the alternative exon restored the affinity of mAB
13A4 to PROM1.
Conclusion: mAB 13A4 recognizes a structural epitope that is stabilized by two of the
extracellular domains of PROM1. The results of our mutagenesis are consistent with the
computationally predicted helical bundle structure of PROM1 and point to the utility of mAB 13A4
for evaluating the effect of mutations on the PROM1 structure. We show that the PROM1 isoform
composition needs to be considered when interpreting tissue and developmental expression data
produced by mAB 13A4.
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3.3 Introduction
Prominin (PROM1, CD133, AC133) was identified as the antigen of monoclonal antibodies
raised against human hematopoietic progenitors and mouse neuroepithelial cells

1–3

. PROM1 is

a glycosylated membrane protein with five transmembrane and three extracellular domains

1,2

.

PROM1 is a member of a conserved family of proteins involved in modulating the architecture of
cellular protrusions, such as microvilli and cilia 4–6. Mutations in the human Prom1 gene have been
reported in various types of retinal degeneration and are primarily associated with cone-rod
dystrophy

7–11

. Mouse models lacking Prom1 or expressing the dominant Arg373Cys mutant

recapitulate the retinal degeneration phenotype and display defects in disk morphogenesis 9,12,13.
Most mutations in Prom1 are recessive and result in loss of function due to premature stop
codons. Notably, three missense mutations, Leu245Pro, Arg373Cys, and Asp829Asn, have
dominant inheritance patterns 7.
The Prom1 gene produces multiple splicing isoforms that can be tissue and cell type
specific 15–19. Six alternative exons in the mouse Prom1 can potentially produce 24 splice variants,
although to date, only eight have been enumerated

15,16,20

. In mouse photoreceptor cells, a

microexon, exon 19, introduces 6 amino acids in the photoreceptor-specific SV8 isoform of Prom1
16,17

. While this exon is present in most vertebrate clades, it is not used in the primates, including

humans, due to mutations that disrupt either the 3’ or the 5’ splice site of the exon (Figure 2B).
Despite playing conserved and critical functions, the Prominin-1 genes show relatively low
conservation of their primary amino acid sequence. For example, human and mouse PROM1
proteins share approximately 61% sequence identity 21. Consequently, antibodies to PROM1 tend
to be species specific. In mice, the rat monoclonal antibody mAB 13A4 is the reagent typically
used to detect PROM1. The mAB 13A4 antibody was raised against an extract from mouse
neuroepithelium 2. Its antigen was cloned by screening for reactivity with mAb 13A4 of a phage
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library of mouse kidney cDNA 2. mAB 13A4 is speculated to recognize part of the third extracellular
domain of PROM1 because of a truncating mutation in that domain that abolishes its binding, but
the epitope was never mapped 8,22.
Prompted by a discrepancy between the PROM1 protein levels measured in the postnatal
retina by mAB 13A4 and the mouse monoclonal antibody to PROM1 ab27699, we set out to map
the epitope of mAB 13A4. We found that mAB 13A4 recognizes a structural epitope that can be
disrupted by deletions in the second and third extracellular domains. Furthermore, the affinity of
mAB 13A4 to PROM1 is dramatically reduced by the inclusion of the photoreceptor-specific exon
19a.

3.4 Materials and Methods
Animals
The Prom1rd19 mice were acquired from the Jackson laboratory (B6. BXD83Prom1rd19/Boc, Stock No: 026803). All experiments were conducted with the approval of the
Institutional Animal Care and Use Committee at West Virginia University.
Prom1 clones
We obtained a full-length Mammalian Gene Collection clone of the mouse photoreceptorspecific isoform (SV8) of Prom1 from Horizon Discovery (clone ID: 4502359, NCBI accession:
BC028286). Gibson assembly (NEB# E5510) was used to generate Flag-tagged Prom1 clones
and deletion mutants in pcDNA3.1+ (Invitrogen). The primers used for cloning are listed in Online
Supplementary Table 1.
Cell culture and transfection:
Mouse Neuro-2a (N2a) neuroblastoma cells (ATCC CCL-131) were cultured in OptiMEM
reduced serum media buffered with sodium bicarbonate and supplemented with 4% (v/v) fetal
bovine serum (FBS, R&D Systems, Minneapolis, MN). The cells were grown at 37 ◦C in a 5%
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CO2 humidified atmosphere. The cDNA clones were transiently transfected in N2a cells using
polyethylenimine

23

. Cell lysates for Western blot analysis were collected at 24 hours post-

transfection.
Denaturing Gel Electrophoresis and Western Blot
Flash-frozen mouse retinas and N2a cells transiently transfected with Prom1-expressing
constructs were lysed in RIPA buffer (50 mM Tris HCl-PH 8.0, 150 mM NaCl, 1.0% TritonX-100,
0.5% Sodium Deoxycholate, 0.1% SDS) supplied with protease (Sigma-Aldrich catalog# 5351401ML) and phosphatase inhibitors cocktail (Sigma-Aldrich catalog # P5726-1 ML). After
homogenization, the lysate was incubated on ice for 10 mins, then cleared by centrifugation for
15 mins. 20 μg of protein extract was resolved in 4-20% polyacrylamide SDS–PAGE gel and
transferred onto polyvinylidene difluoride (PVDF) membranes (Immunobilon-FL, Millipore). After
blocking with BSA in PBST (Phosphate- buffered saline with 0.1% Tween-20), the membranes
were probed with primary antibodies overnight at 4 °C, followed by incubation with fluorescently
labeled (Alexa Fluor 647 or 488, Jackson ImmnuoResearch) secondary antibodies for 1 hour at
room temperature. The membranes were then imaged on Amersham Typhoon Phosphorimager
(GE Healthcare).
Serial dilution was performed to ascertain the linearity of western blot quantification (S1
Fig). Lysates of cells transfected with the s8(-ex19) clone were diluted with extracts from cells
transfected with an empty vector to maintain equal loading. The lysates were then probed on
western blot by mAB 13A4 and imaged as described above. Linear regression was performed in
Graphpad Prism on the scaled and normalized band intensities.
Blue Native Polyacrylamide Gel Electrophoresis (BN PAGE)
The samples were lysed in BN PAGE sample buffer (Thermo Fisher Catalog# BN2008)
containing 1% digitonin and protease inhibitors, following the manufacturer's recommendation.
The lysates were treated with benzonase at room temperature for 30 minutes to shear the DNA
and cleared by centrifugation for 15 mins. Prior to electrophoresis, the samples were mixed with
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Coomassie G-250 and resolved in 3-12% NativePAGE Bis-Tris gel (Invitrogen Catalog
#BN1003BOX) as per the manufacturer’s recommendations. The gels were then transferred on
PVDF membranes (Immunobilon-FL, Millipore) following the manufacturer's recommendations.
After transfer, the membranes were incubated in 8% acetic acid for 15 minutes to fix the proteins,
rinsed with deionized water, and air-dried. The membranes were blocked, probed with antibodies,
and imaged as described above in the denaturing gel electrophoresis protocol.
Antibodies
The primary and secondary antibodies that were used throughout our studies include the
following: mouse anti-β-tubulin (1:5000; catalog # T8328-200ul, Sigma-Aldrich, St. Louis, MO),
mouse anti-GAPDH (1:20,000; custom made), mouse anti-flag M2 (1:1000, catalog # F1804200UG, Sigma-Aldrich, St. Louis, MO), rat anti- Prom1(1:1000, clone ID:13A4, ThermoFisher,
Waltham, MA), mouse anti-GFP HRP conjugated GFP tag ( 1:1000, Cat #HRP-66002,
ThermoFisher, Waltham, MA), mouse anti-Prom1 (1:1000, Cat #ab27699, Abcam, Cambridge,
MA), Alexa Fluor 647 conjugated AffiniPure Goat-Anti rabbit IgG (1:3000, Jackson
ImmunoReserach, West Grove, PA), Alexa Fluor 488 conjugated AffiniPure Goat-Anti mouse IgG
(1:3000, Jackson ImmunoReserach, West Grove, PA), and Alexa Fluor 647 conjugated AffiniPure
Goat-Anti rat IgG (1:3000, Jackson ImmunoReserach, West Grove, PA).
Statistical analysis
The two-way analysis of variance (ANOVA) with Tukey Honest Significant Differences
(HSD) post-hoc test or two-tailed unpaired Student’s T-test was used to determine statistical
significance as indicated in the results section. Quantitative data are presented as the mean of
three biological replicates ±standard error of the mean.
Protein structure prediction and visualization
The RobeTTa structure prediction service was used to create models of the photoreceptorspecific SV8 (RefSeq NP_001157057) isoform that contains exon 19a and the ubiquitously
expressed isoform SV2 (RefSeq NP_001157049) that lacks exon 19a (see Figure 2A for
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alignment of the two sequences). To create images of the structures, we used Pymol (The PyMOL
Molecular Graphics System, Version 2.0 Schrödinger, LLC).

3.5 Results
Discrepancy in the PROM1 protein levels measured by the mAB 13A4 and ab27699
antibodies
While investigating the expression of PROM1 in the postnatal mouse retina, we noticed
that when measured by mAB 13A4, the PROM1 protein levels peaked at postnatal day 8, five
days before the peak recorded by ab27699 (Figure 1A and B). Furthermore, mAB 13A4 showed
approximately three to five-fold lower levels of PROM1 at postnatal days 13 and beyond
compared to ab27699 (Figure 1A and B). Two-way ANOVA showed a significant effect of the day
after birth (F(9)=55.26, p-value<2*10-16) and the antibody used (F(1)=365.48, p-value<2*10-16) on
the measured PROM1 protein levels. According to the Tukey HSD post-hoc test, the signals
detected by mAB 13A4 and ab27699 were significantly different starting from postnatal day 13. It
is possible that cross-reactivity of ab27699 to other proteins of a size similar to PROM1 in the
retina could have compromised its performance. To rule out cross-reactivity, we probed retinal
extracts from wild-type and homozygous Prom1rd19 mutant retina with mAB13A4 and ab27699.
The Prom1rd19 allele contains a premature stop codon that abolishes the expression of the
PROM1 protein 24. Both antibodies recognized a protein just over 100KDa in size in the wild-type
retina that was not detected in the extract from the Prom1 knockout retina (Figure 1C). Thus, the
discrepancy in the signal between mAB13A4 and ab27699 is likely due to differences in the
availability of the epitopes recognized by the two antibodies.

Reduced affinity of mAB13A4 to PROM1 carrying the photoreceptor-specific exon 19a
A short 18nt microexon, exon 19a, is included in the Prom1 transcripts, specifically in
photoreceptor cells (Figure 2)

17

. The inclusion rate of exon 19a starts to increase at postnatal
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day 3, and the exon 19a containing transcripts become dominant in the retina after postnatal day
8 17. The peptide encoded by exon 19a is inserted in the third extracellular loop of PROM1 (Figure
3A), which is also the proposed location of the mAB 13A4 epitope

8,22

. Thus it was possible that

inclusion of exon 19a disrupts the epitope of mAB 13A4 while leaving intact the epitope of
ab27699. To determine if exon 19a disrupts the mAB 13A4 epitope, we generated Flag-tagged
cDNA clones that either contain (SV8) or skip (SV8(-Ex19a)) the photoreceptor-specific exon 19a.
The cDNA were transfected in N2a cells, and their expression was probed with mAB 13A4,
ab27699, and anti-Flag antibodies. As expected, mAB 13A4 showed a significant reduction in its
affinity to the cDNA containing exon 19a compared to the epitope tag (Figure 3B). The inclusion
of exon 19a had no effect on the affinity of the ab27699.
mAB 13A4 recognizes a structural epitope
To map the epitope of mAB13A4, we created a series of tiled deletion mutants of the SV8(Ex19a) cDNA that originated at the point where exon 19a would have been inserted and
progressed in the C-terminal and N-terminal direction (Figure 4A). The deletion mutants covered
108 amino acids of sequence. Nine out of ten deletions resulted in complete loss of the mAB
13A4 epitope (Figure 4B). Only the most C-terminal deletion in the series (D+4) could be detected
by mAB 13A4. The results of the deletion mutagenesis indicate an epitope for mAB 13A4 that is
at least 94 amino acids in length. This length far exceeds the size range of linear peptide epitopes
and strongly argues for a structural rather than a linear epitope 25,26.
The western blots shown on Figures 1, 3, and 4 were performed using denaturing gel
electrophoresis. Detecting a structural antigen using this approach would require the protein to
renature on the membrane prior to probing with the primary antibody. Consequently, our results
may reflect the propensity of the splicing isoforms and deletion mutants to renature rather than
the genuine affinity of the mAB 13A4 to the native proteins. To test if this is the case, we resolved
the proteins produced by the SV8 and SV8(-Ex19a) clones on native gel electrophoresis and
probed the membranes with mAB 13A4 and anti-Flag antibodies. The exon 19a-containing protein
93

was recognized with significantly reduced affinity (Figure 4C), demonstrating that the inclusion of
exon 19a alters the structure of PROM1 rather than affecting its folding rate. Interestingly, under
native conditions, PROM1 formed higher order complexes.
Computationally derived PROM1 tertiary structure predicts the effect of sequence
manipulation on the mAB13A4 epitope
To better understand the nature of the mAB 13A4 epitope and how our deletion
mutagenesis affected it, we needed a tertiary structure for PROM1. There are no empirically
derived structures of PROM1. Nevertheless, recent advances in computational approaches for
structure prediction are producing remarkably accurate structures

27,28

. We used the RobeTTa

structure prediction service to model the structures of the mouse PROM1 isoforms SV8 and SV2
(Figure 2A) 27. The photoreceptor-specific SV8 isoform differs from canonical SV2 isoforms by the
inclusion of exon 19a in the third extracellular domain and the skipping of two exons in the
cytoplasmic C-terminal domain. The structures predicted by RobeTTa for the SV8 and SV2
proteins were in excellent agreement with each other and with the structure of the human PROM1
predicted by Alpha Fold 29. In the predicted PROM1 structure, the second and third extracellular
domains each form two antiparallel alpha helices that are continuous with the adjacent
transmembrane domains. The alpha helices formed by the second and third extracellular domains
and the adjacent transmembrane domains are packed in a four-helix bundle (Figure 5A). Inclusion
of exon 19a lengthens the second helix of the third extracellular domain, causing a kink in the
bundle (Figure 5A). Mapping the positions of the deletions that disrupted the mAB 13A4 epitope
on the PROM1 structure showed that they were located towards the middle portion and the tip of
the helical bundle. The D+4 mutation, which was the only one that did not result in loss of the
mAB 13A4 epitope, was the furthest from the tip of the helical bundle. Based on the positions of
the deleted segments and the six amino acids encoded by exon 19a in the PROM1 structure, we
made three predictions: (i) deleting six amino acids adjacent to exon 19a (Del AA 6) in the
photoreceptor-specific PROM1 isoform should shorten the helix compensating the inclusion of
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exon 19a, and restore the mAB 13A4 epitope (Figure 5B, colored dark blue on the structure of
SV8); (ii) Deletion of a 15 amino acid segment (D-7) in the third extracellular domain opposite to
D+4, should retain the mAB 13A4 epitope due to its distance from the location of the epitope in
the upper half of the helical bundle (Figure 5B, colored red on the structure of SV2); (iii) Deletion
of a 15 amino acid segment (Del EC 2) in the upper half of the second extracellular domain of
SV8(-Ex19a) should result in loss of the mAB 13A4 epitope (Figure 5B, colored sky blue on the
structure of SV2). All three predictions proved to be accurate when the proteins expressed from
the corresponding clones were analyzed by Western blot (Figure 5C). Deletion of the six amino
acid long segment recovered the mAB 13A4 epitope in the photoreceptor-specific SV8 isoform.
Conversely, the deletion in the second extracellular domain of the protein encoded by the SV8(Ex19a) clone resulted in complete loss of the epitope. Finally, deletion D-7 in SV8(-Ex19a)
preserved the epitope, although the affinity of mAB 13A4 was reduced. The results of the
structure-directed mutagenesis provide further support for mAB 13A4 recognizing a structural
epitope. In addition, our results demonstrate the utility of the modeled PROM1 structures.

3.6 Discussion
To reliably interpret results from techniques that employ antibodies, it is essential to know
the antibody epitope, its specificity, and its affinity. While mapping the antibody epitope may be
important, it is usually not considered necessary as long as specificity to the target can be
demonstrated. Such practice leaves a gap that, in certain cases, can have a significant impact on
interpreting experimental results, as we show here for mAB 13A4. mAB 13A4 is widely used to
detect the mouse PROM1 protein because of its excellent specificity and the lack of alternatives
with comparable performance. As of the time of writing of this article, there are over 300
publications in Google Scholar citing the 13A4 antibody in the context of PROM1. Here we show
that the mAB 13A4 antibody recognizes a structural epitope, and its affinity for naturally occurring
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PROM1 isoforms can vary dramatically. When used to measure PROM1 levels in the retina, mAB
13A4 underestimated the protein amount by a factor of five compared to ab27699.

To determine the exact mAB1 13A4 epitope unequivocally will require determining the
structure of the PROM1 - mAB 13A4 complex, which is beyond the scope of the current work.
Nevertheless, we show that mAB 13A4 is a useful reagent for detecting perturbation in PROM1
structure as changes to the PROM1 sequence that were hundreds of amino acids apart abolished
the mAB 13A4 epitope. Furthermore, we created three mutations in PROM1 guided by the
computational model of its structure. The effect of these mutations on the mAB 13A4 epitope was
in line with the predicted structure, providing empirical evidence for its validity. Finally, we
demonstrate that under native conditions, PROM1 can form higher order complexes, providing a
possible path towards understanding the dominance of Prom1 mutations in patients with conerod dystrophy.
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3.9 Figures

Figure 3-1 Photoreceptor-specific splice variant of PROM1

Figure 1: Photoreceptor-specific splice variant of PROM1. A) Alignment of the photoreceptorspecific s8 isoform of PROM1 (RefSeq NP_001157057) to the ubiquitously expressed isoform s2
(RefSeq NP_001157049). The amino acids encoded by the photoreceptor-specific exon 19 are
shown in bold and shaded in gray. The third extracellular domain is underlined. B) Alignment of
vertebrate exon 19 sequences including the adjacent 3’ and 5’ splice sites. Mutations inactivating
the splice sites in primates are shaded in gray.

100

Figure 3-2 Discrepancy in the levels of PROM1 as determined by the mAB 13A4 ab27699 antibodies

Figure 2: Discrepancy in the levels of PROM1 as determined by the mAB 13A4 ab27699
antibodies. A) Immunoblotting for PROM1 in mouse retina lysate collected between postnatal
day 0 (P0) and postnatal day 110 (P110) using the mAB 13A4 and the ab27699 antibodies. Antiꞵ-tubulin serves as a loading control. B) Quantification of Prom1 level in retina lysates using the
mAB 13A4 and the ab27699 antibodies. Error bars represent the standard error of the mean
(n=3). Two-way ANOVA was used to assess the effect of the postnatal day and the antibody used
on the PROM1 signal. The statistical significance of the signal mAB 13A4 compared to ab27699
for each day was calculated by Tukey HSD post-hoc test. Tukey HSD p-values of less than 0.001
from the post-hoc test are indicated by “***. “ C) Test of the specificity of mAB 13A4 and ab27699
antibodies for detecting PROM1 using the retinal lysate from wild-type mice and Prom1rd19
mutants that do not express PROM1 protein. Arrow indicates the position of the expected PROM1
band.
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Figure 3-3 The affinity of mAB 13A4 to PROM1 is affected by alternative splicing

Figure 3: The affinity of mAB 13A4 to PROM1 is affected by alternative splicing. A)
Schematic representation of the PROM1 structure showing the position of exon 19 (black) in the
third extracellular domain (EC 3) of the photoreceptor-specific PROM1 isoform s8 (Adapted from
Corbeil et al [23]). Extracellular domains one through three are labeled as EC 1, EC 2, and EC 3,
respectively. B) Western blot of recombinant s8 and s8 lacking exon 19, s8(-Ex19), expressed in
N2a cells with mAB 13A4, ab27699, and antibody to the Flag epitope. Transfection with an empty
pcDNA3.1 vector (EV) was used as a negative control. All transfections were spiked with a vector
expressing GFP to control for transfection efficiency. C) Quantification of mAB 13A4 and ab27699
signals relative to the signal from the Flag-tag antibody. Error bars represent the standard error
of the mean (n=3). Unpaired Student’s t-test was used to assess the statistical significance, and
the p-value is indicated on the chart. D) Deglycosylated PROM1 isoform s8 is recognized by mAB
13A4 with reduced affinity compared to protein lacking the amino acids encoded by exon 19.
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Figure 3-4 Mapping of the mAB 13A4 epitope

Figure 4: Mapping of the mAB 13A4 epitope. A) Sequence of the third extracellular domain.
Underlining shows the positions of the deletions used for epitope mapping. The deletion variants
were generated starting from the s8 clone lacking exon 19, s8(-Ex19). Solid triangle above the
sequence shows the position where exon 19 is inserted in the photoreceptor-specific isoform. B)
Western blot analysis of PROM1 deletion mutants expressed in N2a cells using mAB 13A4 and
Flag-tag antibodies. All mutants with the exception of D+4 resulted in the loss of the mAB 13A4
epitope. Transfection with an empty pcDNA3.1 vector (EV) was used as a negative control. All
transfections were spiked with a vector expressing GFP to control for transfection efficiency. C)
Native gel Western blot analysis using mAB 13A4 and Flag-tag antibodies of N2a cell lysate
transfected with either an empty vector (EV), s8, or s8(-Ex19). D) Quantification of mAB 13A4
signals relative to the signal from the Flag-tag antibody in native gel electrophoresis western blot.
Dots represent individual data points. Line and error bars the mean and the standard error of the
mean (n=5). Unpaired Student’s t-test was used to assess the statistical significance and the pvalues were less than 0.01 (indicated by “**”).
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Figure 3-5 Computationally derived tertiary structure of PROM1 predicts the effect of mutations on the mAB 13A4
epitope

Figure 5: Computationally derived tertiary structure of PROM1 predicts the effect of
mutations on the mAB 13A4 epitope. A) Sequence segments from the PROM1 protein with the
amino acids deleted in clones Del EC2, D-7, and Del AA6 underlined. B) Partial structure of
PROM1 isoforms s8 and s2 showing the positions of the segments deleted in the experiments on
Fig 4 and on panel C of this Fig on the tertiary structure of PROM1. Exon 19 is shown in red on
the structure of s8. The deletion Del AA6 analyzed on panel C is shown in blue on the structure
of s8. On the structure of s2, cyan color indicates deletions D-1 through D-6, and orange indicates
deletions D+1 through D+4 from the experiments shown on Fig 4. Also, on the structure of s2, the
positions of the deletions D7 and EC2 analyzed on panel C are shown in red and sky blue,
respectively. Arrow points to the position of the excluded exon 19 in s2. C) Western blot analysis
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of PROM1 deletion mutants expressed in N2a cells using mAB 13A4 and Flag-tag antibodies. All
transfections were spiked with a vector expressing GFP to control for transfection efficiency.

3.10 Supplementary information

Supplement Figure 3-6 Linearity of western blot quantification
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Supplement Figure 1. Linearity of western blot quantification. A) Western blot replicates.
Serial dilution of extract expressing clone s8(-Ex19) with an extract from cells transfected with an
empty vector was probed by mAB 13A4. B) Plot showing scaled normalized signal intensities for
each replicate and linear regression with 95% confidence interval. R2=0.93, p-value=1.8*10-12.

Supplement Figure 3-7 Gel images of replicates related to Figures 1A and 1B

Supplement Figure 2. Gel images of replicates related to Figures 1A and 1B. Boxes denote
the parts of the images used in preparing Figure 1A.
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Supplement Figure 3-8 Gel images of replicates related to Figures 3B and 3C

Supplement Figure 3. Gel images of replicates related to Figures 3B and 3C. Boxes denote
the parts of the images used in preparing Figure 3B.
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Supplement Figure 3-9 Deglycosylation of PROM1 deletion mutants

Supplement Figure 4. Deglycosylation of PROM1 deletion mutants. Lysates from N2a cells
were treated with deglycosylation mix II (NEB) and analyzed on western blot next to untreated
controls. The blots were probed with mAB 13A4 and anti-Flag antibodies as indicated.
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Supplement Figure 3-10 Native gel electrophoresis of PROM1 clones s8 and s8(-Ex19)

Supplement Figure 5. Native gel electrophoresis of PROM1 clones s8 and s8(-Ex19). The
proteins were resolved by native blue electrophoresis, transferred to PVDF membranes, and
probed with mAB 13A4 and anti-Flag antibodies as indicated. Lanes containing the size standard
were cut from the membranes after the transfer and stained with Ponceau S. The size standard
lanes and probed membranes were imaged on Typhoon Phosphorimager (GE Healthcare).
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Supplement Figure 3-11 Protein structure predictions for PROM1 isoform s8 and deletion clones

Supplement Figure 6. Protein structure predictions for PROM1 isoform s8 and deletion
clones. Extracellular domains 2 (EC2) and 3 (EC3) are indicated on the predicted structures by
green and pink color, respectively. Exon 19 and the amino acids deleted in Del AA6 are colored
on the structure of the s8 isoform in red and blue, respectively. The deletions for clones Del EC2
and D7 are colored on the structure of s8(-Ex19) in light blue and red, respectively. In structures
that do not contain exon 19, arrows indicate the position of the junction between exons 18 and
20. The structures of s8 and Del EC2 have pronounced kinks near the top of the bundle when
compared to the structures of s8(-Ex19). Del AA6, and Del EC2.
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4. Chapter 4
4.1 Discussion
The Musashi paralogs, MSI1 and MSI2, are expressed in various stem cell populations,
consistent with their role in maintaining the stemness status opposing differentiation [48–51]. In
contrast, our recently published work shows that the Musashi proteins maintain high protein levels
in the adult retina (Figure.1) [52,53,69]. Musashi proteins are also readily detectable in mature
neurons in the retina and CNS [52–54,69].
Furthermore, the Musashi proteins have been
shown to function redundantly when regulating
proliferation in stem cells [25,51,55]. The functional
redundancy in stem cells leads to the notion that the
two paralogs act similarly in the differentiated tissues.
Therefore, numerous studies focused solely on
investigating the first member, MSI1 as a model
representing

the

Musashi

family,

leaving

MSI2 Figure 4-1 The Musashi proteins
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and in combination in mature photoreceptors. This chapter will discuss our findings on the role
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of the Musashi proteins in mature photoreceptors. I will conclude by going over some suggestions
for future direction.

Figure 4-2 The switch in Musashi proteins expression during retinal postnatal development

Figure 2: The switch in Musashi proteins expression during retinal postnatal
development. A) immunoblot showing the decrease in MSI1 and increase in MSI2 level as
photoreceptors mature. B) Quantification of relative MSI1/2 protein level. Error bars represent
standard error of the mean (SEM, n=3). pairwise t-test after FDR correction is indicated as
follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗=p < 0.001. FDR, false discovery. P0 (postnatal day 0).
Published figure in Sundar & Matalkah et al, 2020.

4.1.1 The Musashi proteins are required for the maintenance of photoreceptor neurons
To investigate the functional role of the MSI1/2 proteins in fully developed photoreceptor
neurons, we utilized a tamoxifen inducible CRE line under the control of a photoreceptor-specific
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for the Musashi proteins in maintaining terminally differentiated cells.
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4.1.2 The Musashi proteins function redundantly to maintain the photoreceptor neurons
In our recently published work, we showed that the Musashi expression is developmentally
regulated, with MSI1 expression peaking early around postnatal day 4 (PN4) and MSI2 levels
rising after PN13 (Figure.2) [52]. Building upon these findings, we hypothesized that MSI2 might
have a unique role in maintaining mature photoreceptor cells. To test our hypothesis, we sought
to investigate the functional role of the Musashi individually in mature photoreceptors. Contrary to
our expectations, the single deletion of Msi1 or Msi2 in mature photoreceptors did not produce
any functional or morphological phenotype. This suggests that the Musashi proteins are
redundant in maintaining the mature photoreceptor neurons. The observed functional overlap can
be explained by the high expression of the two proteins in mature photoreceptors and the
sequence homology reported between the two paralogs. For example, the RNA binding domains
of MSI1 and MSI2 are 77% (RRM1) to 92% (RRM2) identical and recognize the same UAG
sequence motif. Thus, the functional redundancy we observed in mature photoreceptor cells
recapitulates the previously reported redundancy between MSI1 and MSI2 in other cell types
[51,55].
The partial redundancy we reported previously in Sundar et al. is due to the timing of the
knockout relative to the timing of the expression of Msi1 and Msi2 in photoreceptor development.
In Sundar et al., the single deletion of Msi1 in rod progenitor cells is initiated at embryonic day 9
(E9). In the critical period for photoreceptor development immediately after the birth of the
animals, the Msi1 knockout cannot be fully compensated by Msi2, which is expressed at low levels
until postnatal day 13 (Figure.2). In contrast, Msi1 can fully compensate for the loss of Msi2 at
this point as it is highly expressed. In the current study, I induced the single deletion in fully
developed photoreceptor cells at postnatal day 30, a developmental time point where both Msi1
and Msi2 are expressed at high levels.
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4.1.3 The Musashi proteins bind intronic and 3'UTR at UAG rich region
To identify the in vivo targets of the Musashi proteins in the retina, we performed UV
Cross-Linking and Immuno-Precipitation, followed by a high throughput sequencing of the
associated RNA fragments (CLIP-Seq). The CLIP-seq is a technique that identifies the direct
targets and the exact Musashi-binding sites on the mRNA features. Given the functional
redundancy we observed between MSI1 and MSI2 in the context of mature photoreceptor
neurons, we presumed that both proteins would bind the same RNA targets in the retina. Thus,
we performed CLIP-Seq only for MSI1.
Our CLIP-Seq experiment shows that the Musashi bind a UAG-containing motif found at
the 3’-UTR (59.7% targets bound by MSI1) and the intronic region (32.7%) of a broad set of retinal
transcripts. The sequence motif bound in vivo by MSI1 matches the UAG core motif previously
identified by the in vitro structural studies [59,60,62]. This match gives us confidence that most
binding sites we identified are directly bound by Msi1 and are not experimental artifacts.
The distribution of Msi1 binding to introns and 3’-UTRs supports a dual function for the
proteins in pre-mRNA processing and regulation of protein expression. These functions are
consistent with the nuclear and cytoplasmic subcellular localization reported for the Musashi
proteins in the context of mature photoreceptor neurons and the two roles reported for the
Musashi in regulating splicing and translation [53,54,66,69]. Interestingly, most of the MSI1
binding events at the 3’-UTR of transcripts we identified belong to genes encoding proteins critical
for photoreceptor structure and function. Among the identified targets is a list of proteins
associated with phototransduction and outer segment function.
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4.1.4 The Musashi proteins activate alternative exons when bound downstream of them
Previously, we showed that MSI1 is critical for the utilization of photoreceptor-specific
exons [52,66]. Our earlier work suggests the binding of MSI1 to the intronic region downstream
of the alternatively spliced exon leads to its inclusion in the final transcript [66,68]. To determine
if this mode of regulation is standard in vivo, we combined the binding site of MSI1 identified by
the CLIP-seq and the Musashi-dependent alternative exons identified by the RNA-seq. While the
CLIP-seq identifies the physically bound RNA targets, the mRNA splicing following Msi1/Msi2
depletion can be assessed by RNA-seq. The RNA-seq was done on RNA I isolated from the retina
collected from the WT and KO mice at D21 post-tamoxifen injection. We selected this time point
to ensure enough time was given to capture any changes in the transcriptome induced by the
depletion of Msi1/2 but before any detectable changes occurred on the viability of photoreceptor
cells. We identified 280 genes switching isoforms due to Msi1/Msi2 depletion. Merging the two
data sets collected from CLIP-seq and RNA-seq generates an RNA binding protein splicing map
(RBP-map) that provides information about the specific binding position on the mRNA features
and its effect on splicing outcome as described previously [17]. The generated RBP-map shows
that the binding activity of MSI1 occurs at the UAG core motif located in the intronic region
downstream of the alternatively regulated exons, resulting in its inclusion in the final transcript.
For example, exon 19 in the Prom1 gene, that's normally included in the final transcript, was
excluded upon Msi1/Msi2 deletion.
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4.1.5 The microexons within the Ttc8, Cep290, Cc2d2a and Cacna2d4 genes are
dispensable
Given the in vivo evidence of MSI activity in controlling alternative splicing in mature
photoreceptor cells, we sought to investigate the biological significance of alternative splicing on
the function of photoreceptor cells. Among the predicted splicing targets of MSI that we selected
to study include the microexon 2A in Ttc8 encoding for 10 residues (EPAPDLPVSQ), exon 32 of
the Cc2d2a gene (MSDMLKK), exon 8 of the Cep290 gene (NKRLKKK), and the microexon 34
in Cacna2d4 gene encoding for 8 amino acids (AKSVFHHS). All these microexons are
photoreceptor-specific and deeply conserved in vertebrates spanning a 230 million years of
evolution from lizards to humans. Our eCLIP-seq results show that the inclusion of these
microexon is due to the MSI binding to the intronic region downstream of the alternatively spliced
exon. Surprisingly, neither the single removal of the micorexons (Ttc8, Cc2d2a, Cep290,
Cacna2d4) nor the combined triple exon KO (Ttc8, Cc2d2a, Cep290) produced a phenotype up
to one year of age. The absence of phenotype in our exon knockout animals raises questions
about the strong natural selection enforcing the conservation of such functionally neutral exons.
One explanation for the dilemma is that the conservation of these microexons is probably due to
purifying selection, where only deleterious mutations are eliminated, which subsequently led to
their deep conservation
Regardless, one should keep in mind that the lack of a phenotype from the exon knockout
model cannot completely rule out a role for splicing in shaping the phenotype of the Msi knockouts.
What is interesting about these microexons is that they tend to spike as the cells within the retina
exit the mitotic cycle and differentiate, at the time of synaptic formation and function, suggesting
a role in the late maturation stages [66]. Therefore, the absence of the phenotype could possibly
be due to the lack of a cumulative effect over the animal's lifespan that's needed for the
manifestation of the phenotype. Currently, our data suggest that the loss of function upon the
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depletion of Msi in mature photoreceptors is probably imposed by the role of Msi in regulating
translation rather than its role in regulating alternative splicing.
4.1.6 The Musashi proteins promote the expression of a large number of photoreceptorspecific proteins.
Since 3’UTRs are abundantly bound by the Musashi proteins and are commonly used to
regulate the turnover and translation of mRNA, I sought to investigate if the Musashi is involved
in regulating protein synthesis [25,36,56,59,75]. To accomplish this, I turned to proteomics to
quantify the steady state level of the retinal proteome. We performed global proteome
quantification using the isobaric tag labeling and tandem mass spectrometry (TMT). The TMT
isobaric tagging approach enables precise and reproducible quantification of the relative protein
abundances in KO relative to their littermate control. In the experimental design, we determined
the proteomics changes in the retina isolated from the KO and the littermate control collected on
day 21 post-tamoxifen injection. The retinal proteome captured by the mass spectrometry was
over 7000 proteins in total. We identified the differentially expressed proteins as the ones having
a logFC (logarithm of fold change) >1.5 or <−1.5 and false discovery rate (FDR) ≤0.05. It should
be noted that these criteria selected 165 proteins that were differentially expressed in KO samples
relative to their WT littermate control. Upon closer examination, the data show that the
differentially expressed proteins can be divided into two sets: one set shows a significant
reduction upon the Msi1/Msi2 deletion. In contrast, the other set includes significantly upregulated
proteins. Guided by the gene ontology analysis, we show that part of the downregulated proteins
is involved in the phototransduction pathway (GNB1, GNAT1, GNAT2, CNGA1, PDE6B, PDE6A,
and GUCA1B). We also observed a significant decrease in specific ciliary and outer segment
proteins. Some are essential for the trafficking in and out of the cilia (TTC8 and RPGR), while
others are structural components of the photoreceptors' outer segment (ROM1 and PRCD).
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As per the upregulated proteins, the gene ontology analysis suggests that these are
associated with the activation of Muller and Microglia. Among the glial markers that we observed
to be upregulated include the (GFAP, A2M, and GS). The fact that the Musashi deletion was
specific to photoreceptor neurons strongly suggests that the upregulation that we observe in glial
markers is not directly regulated by Musashi but is a response to changes in photoreceptor cells
caused by the Musashi knockout. Glial activation is a common defense mechanism activated in
response to neurodegeneration. Regardless of the origin of the insults, whether mechanical,
infection, or genetics, glial activation is believed to be elicited by the stressed photoreceptors cell
to trigger the secretion of neuroprotective factors by the glial cell [76–78]. This mechanism has
been reported in several retinal dystrophies models and is not unique for the Musashi loss.
Collectively, using proteomics, we identified a trend toward a significant reduction in the
protein levels in response to the Msi1/Msi2 deletions; however, this was not globally followed, as
many other proteins were not impacted by the Musashi removal, indicating that the depletion of
Musashi does not have a generalized effect. This eliminates the possibility that the reduction in
protein expression we observed was due to photoreceptors degeneration. This notion is further
backed by the normal physiological and morphological analysis of the knockout animals at the
time the experiments were carried out (e.g., day 21 post injection). Furthermore, the fact that the
CLIP-seq also identified all of the downregulated proteins measured by the mass spectrometry to
be directly bound by Musashi to their mRNA 3'UTRs supports a model involving direct regulation.
To determine if the changes we see in the protein level are associated with changes in
the transcript levels, we measured the steady-state mRNA abundance in the retina isolated from
the KO and WT collected on day 21 post-injection (D21) using RNA-seq. It is essential to mention
that RNA-seq only reports the steady state RNA levels and cannot determine if it is due to
translational or stability changes. Other techniques are needed to separate these changes,
including ribosome profiling and stability assay. Interestingly, RNA-seq did not detect an altered
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mRNA level of the genes identified by CLIP-seq with a Musashi-binding site at their 3'UTR. The
unchanged mRNA level between KO and WT suggests that the binding of Msi1 to the 3’-UTR of
these transcripts does not directly impact their transcription or stability but leaves another
possibility of posttranscriptional regulation imposed by the Musashi, such as regulating
translation. Indeed, the Musashi proteins have emerged as master regulators of translation. The
proposed models for the Musashi imposed regulation over translation involve the direct binding
of the Musashi to UAG elements at the 3'UTR of its target transcripts, mediated by the two RNA
recognition motifs (RRM1 and RRM2), and the concurrent binding via a region within its Cterminal domain to the translational machinery [36,64]. As mentioned previously, the Musashi
proteins can use the same region within its C-terminal to bind different factors; thereby, the type
of factor it binds, guided by the cellular context, reflects whether the translation is regulated
positively or negatively. The exact molecular mechanism underlying the Musashi role in regulating
translation and the nature of any cofactors involved is unknown.
It is important to note that the transcriptome and proteomics data reflect upon the changes
in the whole retina while the Msi1/Msi2 depletion was specific to the photoreceptor neurons. To
corroborate our findings, we used the publicly available single cell RNA-seq (scRNA-seq) to track
changes in the transcripts associated with the photoreceptor cells only. Combining the
transcriptome and proteomics together further confirms a trend toward a reduction in the level of
the proteins associated with the photoreceptor neurons with no significant changes in their mRNA
level, except for two photoreceptor-specific proteins (PROM1 and IMPG2), where we observed a
considerable increase rather than a decrease in their protein level with no changes in their
transcripts level as well. Interestingly, both PROM1 and IMPG2 are identified by the CLIP-seq
among the genes that harbor the Musashi-binding site at their 3'UTR.
Taken together, the trend we observed toward a significant reduction in the protein levels
imposed by the Msi1/Msi2 deletion supports a model in which the Musashi proteins act as post119

translational activators for protein expression in mature photoreceptors. Thus, we hypothesize
that the high expression of Musashi proteins in the mature photoreceptors is evolutionarily meant
to keep up with the increased demand for protein synthesis required to maintain the constant
regeneration of the photoreceptor's outer segment. Importantly, failure to replenish the rapid
turnover of the OS while maintaining a constant length is a characteristic of numerous retinal
degenerative disease models.
4.1.7 The splicing alteration imposed by the Musashi disrupted a conformational epitope
within PROM1 recognized by the mAB 13A4.
The mouse Prom1 gene contains at least 27 exons, and its transcript is subjected to
alternative splicing producing multiple splice variants [79,80]. Interestingly, it has been shown that
these splice variants are expressed in a tissue-specific manner, are developmentally regulated,
and may undergo tissue-specific glycosylation [79]. In parallel to the splicing regulation imposed
by the Musashi over Prom1 transcripts identified by eCLIP-seq, our mass spectrometry also
identified an upregulation in the protein level of Prom1 upon the Msi1/Msi2 specific deletion in
photoreceptor neurons. Interestingly, as we attempted to confirm the increased protein level on a
Western blot, we identified a significant discrepancy between the Prom1 level measured using
the widely used mAB 13A4 and the mouse monoclonal antibody to Prom1 ab27699. Hence comes
the work presented in chapter 3 of this study, where I show that alternative splicing significantly
impacts the reactivity of the widely used mAB 13A4 to detect Prom1 on Western blot. Our results
suggest that the mAB 13A4 recognizes a conformational epitope predicted to be composed of a
helix bundle consisting of the two large extracellular loops of Prom1. The inclusion of the
alternatively spliced Ex19 is predicated on producing a kink in the three-dimensional structure of
the helix bundle, disrupting the interaction between the two loops and decreasing the mAB 13A4
reactivity towards Prom1 on a Western blot. This work aimed to bring awareness and careful
attention when choosing a specific antibody as a tool for detecting the protein of interest. Keeping
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in mind, If the protein of interest is subjected to alternative splicing, then different splice variants
can carry specific epitopes. The absence or presence of these epitopes can impede the
immunodetection of the protein leading to a false conclusion.

4.2 Concluding Remarks and Future Direction
Through this study, we utilized genome-wide approaches to monitor the global
transcriptome and proteomic changes induced by Musashi depletion in mature photoreceptor
neurons. Three powerful sequencing tools were applied to characterize the Musashi- binding,
potential targets, and the potential regulated cellular processes. Our study shows that in the
context of mature photoreceptors, the Musashi proteins can impact both protein expression and
pre-mRNA splicing. However, our CLIP-seq revealed that most of the MSI1 binding occurs directly
at the 3’-UTR, in a region rich in UAG, of transcripts that encode for a broad set of proteins
involved in the phototransduction pathway or are critical for the maintenance of photoreceptors'
outer segment (OS) structure and function. Interestingly, while the CLIP-seq identified thousands
of targets to which the Musashi bind, changes in protein expression detected by mass
spectrometry were observed for a small fraction of these targets. The discrepancy between the
target number detected using the two techniques suggests that the Musashi's direct binding to its
target is not enough to impose a regulatory effect, and probably additional factors are needed. It
is also possible that multiple Musashi occupancy is required to produce a regulatory effect, and
the presence of other RNA-binding proteins may outcompete the Musashi for the binding
decreasing its occupancy events. Hence, there is still much to be discovered about the
mechanistic role of the Musashi in mature photoreceptor cells and whether any additional
cofactors are involved, is still unknown.
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Other crucial questions that remain to be answered are how the Musashi regulate protein
expression, directly or indirectly, and what is the exact molecular mechanism. Previous studies
have linked the Musashi to several post-transcriptional mechanisms through which the MSI
regulate its mRNA target. These include miRNA biogenesis, cytoplasmic polyadenylation, and the
regulation of translational initiation. Interestingly in our CLIP-Seq data, we identified interactions
between MSI1 and the highly conserved microRNAs most of which have established roles in
photoreceptor development and maintenance. Among these include the sensory neuron
microRNAs from the miR96/182/183 cluster, let7a/b/c/f, miR9, miR124, miR125a/b, miR181,
mir204 and miR26. Thus, one future direction to take is to use high throughput sequencing to
study the impact of the Musashi deletion on the abundance of miRNA within the mature retina.
The results from this experiment would inform at a global scale if the changes we see in protein
level are due to Musashi’s involvement in miRNA biogenesis.
As mentioned previously the Mussahi proteins have also been linked to cytoplasmic
polyadenylation. Therefore, it would also be interesting to investigate if the global reduction in the
protein level observed upon the deletion of the Msi is imposed by the Musashi role in regulating
the cytoplasmic polyadenylation. Again, global approaches can be used to assess such
association and the results of this experiment can identify at a global scale the changes in the
Poly(A) tail length at a genome-wide level in retinal transcriptomes.
A third experiment direction to take would be to investigate if the changes in protein
expression we identified are imposed by the Musashi’s direct role in regulating the translation rate
of its target mRNA. One direction to answer this question is via the ribosome profiling tool, also
known as ribosomal sequencing (Ribo-seq). When combined with the RNA-sequencing, this tool
can be used to assess the translational rate for every transcript and whether the observed
changes are a result of changes in RNA abundance or changes in the translational rate.
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Additionally, it will be interesting to determine the exact molecular mechanism of how
Musashi regulates its targets' protein levels. I provide evidence that the direct binding of the
Musashi to the 3'UTR of its target at a region rich with the UAG motif leads to a reduction in
protein level. However, the exact molecular mechanism underlying the Musashi-dependent
translational control, or if any cofactors are involved, is still unknown. Another future avenue would
be to identify if other factors are involved and what domains in the Musashi mediate the potential
interactions. Motif enrichment analysis, deletion mutagenesis, coimmunoprecipitation, and
luciferase assay would be powerful tools in determining the potential interactors and the elements
required for the Musashi binding.
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